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Chapter	seven	 Preparation	 and	 characterization	 of	 a	 decellularized	 cartilage	
scaffold	for	ear	cartilage	reconstruction	
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Deformities	 of	 the	 head	 and	 neck	 area	 have	 incredible	 impact	 on	 facial	 appearance	 and	
function.	 They	 are	 the	 result	 of	 congenital	 disease,	 trauma	 (including	 burns)	 or	 tumor	








support.	The	earliest	example	of	 such	 reconstruction	could	be	 found	 in	 the	Hindu	Book	of	
Revelation	 -	 Sushruta	 Samhita	 -	 a	medical	 text	 book	 from	 ancient	 India	 600	 BC.	 Sushruta	
described	various	local	skin	flap	techniques	for	reconstruction	of	the	nose	and	earlobe.	[1]	The	
method	described	by	 Sushruta	 continued	 to	be	practiced	without	 substantial	 variation	 for	
centuries	 and	 variation	 on	 his	 Indian	 forehead	 flap	 rhinoplasty	 is	 still	 used	 for	 soft-tissue	
coverage	of	the	nose	today.	Besides	local	skin	flaps,	the	introduction	of	the	pedicled	distant	
flap	 by	 Tagliacozzi	 (16th	 century)	 [2,	 3]	 and	 the	 introduction	 of	 free	 microvascular	 tissue	
transfer	during	the	late	1950s	[4],	have	extended	possibilities	for	soft	tissue	reconstruction	in	
the	head	and	neck	area.		
Successful	 surgical	 reconstruction	 of	 head	 and	 neck	 defects	 are	 however,	 not	 only	





Currently,	 application	 of	 an	 autologous	 cartilage	 graft	 remains	 the	 standard	 of	 facial	














creative	 ability	 to	 make	 a	 realistic	 framework	 from	 autologous	 cartilage,	 the	 idea	 of	 a	





framework.	However,	due	 to	 its	heterogeneous	outcome,	disappointing	 long-term	survival	
and	severe	donor	site	morbidity,	diced	cartilage	grafting	has	never	achieved	widespread	use.	
In	addition,	its	clinical	use	was	soon	forgotten	after	introduction	of	prefabricated	alloplastic	























translates	 complex	 biological	 science	 into	 a	 living	 prefabricated	 cartilaginous	 framework.	
Future	 surgical	 techniques	 are	 thereby	 simplified,	 improving	 surgical	 outcomes.	 Besides,	
tissue	engineering	aims	to	circumvent	the	resulting	donor-site	morbidity	by	engineering	rather	














this	 collagen	 network,	 PGs	 are	 intertwined,	 of	 which	 aggrecan	 is	 most	 common.	 Their	






Depending	 on	 the	 exact	 composition	 and	 organization	 of	 the	 ECM,	 three	 major	
cartilage	subtypes	can	be	distinguished	with	variable	flexibility	and	mechanobiology:	hyaline,	
elastic	 and	 fibrous	 cartilage.	 (Figure	 3)	 The	 most	 prevalent	 cartilage	 subtype	 is	 hyaline	
cartilage.	It	is	characterized	by	a	homogeneous	ECM	that	mainly	consists	of	collagen	type	2	
fibers,	 PGs	 and	water.	 In	 the	head	and	neck	 area,	 hyaline	 cartilage	 is	 located	 in	 the	nasal	
septum,	trachea	and	larynx.	Outside	this	area,	hyaline	cartilage	is	mainly	found	at	the	articular	
























Depending	 on	 the	 exact	 composition	 and	 organization	 of	 the	 ECM,	 three	 major	 cartilage	 subtypes	 can	 be	
















forms	 cartilage	 tissue	 that	 is	 similar	 to	 that	 of	 native	 tissue.	 The	most	 obvious	 choice	 are	
chondrocytes	 themselves.	 Therefore,	 chondrocytes	 from	 several	 anatomical	 locations	 (e.g.	
joint,	rib,	nose,	ear,	meniscus)	have	been	investigated	for	their	applicability.	[39-60]	Typically,	
autologous	chondrocytes	are	isolated	by	enzymatic	digestion	from	small	cartilage	biopsies,	to	
minimize	 donor	 site	 morbidity.	 However,	 large	 numbers	 of	 chondrocytes	 are	 required	 to	
generate	a	construct	of	reasonable	size.	Therefore,	after	cell-isolation,	cells	are	expanded	in	
vitro	until	 a	 sufficient	 cell	 number	 is	 obtained.	Unfortunately,	 culture-expansion	 results	 in	
chondrocyte	 dedifferentiation:	 they	 change	 phenotypically	 to	 a	 fibroblast-like	morphology	
and	 lose	 their	 chondrogenic	gene-expression	 capacity,	which	usually	 results	 in	 fibrous	and	
mechanically	inferior	cartilage.	[61]	In	recent	years,	considerable	progress	has	been	made	to	
remedy	current	limitations.	Multiple	biological	and	biophysical	cues	have	been	introduced	to	
inhibit	 the	 process	 of	 chondrocyte-dedifferentiation	 and	 improve	 chondrocyte	
redifferentiation,	as	discussed	below.	
Next	 to	 chondrocytes,	 mesenchymal	 stem	 cells	 (MSCs)	 have	 been	 introduced	 and	
demonstrated	to	be	an	attractive	cell	source	for	cell-based	cartilage	repair.	[62]	These	cells	
are	easily	available	 from	several	 tissues,	 including	bone	marrow,	adipose	tissue,	synovium,	
peripheral	 blood,	 dental	 pulp,	 placenta,	 umbilical	 cord,	 and	 skeletal	muscle.	 [63]	Of	 these	
MSCs,	 adipose-tissue-derived	MSCs	 (AMSCs)	 and	 bone-marrow-derived	MSCs	 (BMSCs)	 are	
best	 characterized.	 They	 can	 undergo	 multiple	 population	 doublings	 without	 losing	 their	


































developed	 and	 investigated	 for	 their	 use	 in	 cartilage	 tissue	 engineering.	 [83]	 They	 can	 be	


















cell	 adhesion	 and	 hydrogel	 stiffness	 can	 be	 influenced	 by	 M	 to	 G	 ratio.	 [87]	 Alginate	
mechanical	stiffness	is	however	low	and	range	from	1	to	1000	kPa.	[88]	Although	alginate	itself	
 	






bacterium.	 These	 gram-negative	 aerobic	bacteria	produce	pure	nanocellulose	 fibrils	 in	 the	
presence	 of	 sugar	 and	 oxygen.	 [90]	 More	 recently,	 medical	 devices	 made	 from	 bacterial	
nanocellulose	were	introduced	into	the	clinic	as	wound	and	burns	dressings	(e.g.	Dermafill®,	
Bioprocess®,	XCell®	and	Biofill®),	surgical	meshes	(e.g.	Xylos®,	Macro-Porous	Surgical	Mesh®	and	
Securian®)	 and	 dura	mater	 substitutes	 (Synthecel	 Dura	 Repair®).	 Bacterial	 nanocellulose	 is	
extremely	hydrophilic	and	can	hold	as	much	as	100	times	its	dry	weight	of	water.	[91]	This	
property,	 combined	 with	 the	 distinct	 physical	 and	 mechanical	 properties	 of	 bacterial	
nanocellulose,	 including	 its	 insolubility,	 rapid	 biodegradability,	 tensile	 strength,	 elasticity,	
durability,	 nontoxic	 and	 non-allergenic	 features,	make	 bacterial	 nanocellulose	 a	 candidate	
biomaterial	for	cartilage	TE	in	the	head	and	neck	area.	[92]		
Recently,	 natural	 acellular	 ECM	 scaffolds	 have	 become	 increasingly	 popular.	 These	




date,	 various	 cartilaginous	 structures	 have	 already	 been	 decellularized	 including	 tracheal	







factors.	 (Reviewed	 by	 Wescoe	 et	 al.	 [111])	 Growth	 factors,	 especially	 those	 from	 the	
Transforming	Growth	Factor	beta	family,	Insulin-like	Growth	Factors	and	Fibroblast	Growth	





factors	may	 impede	 cartilage	 regeneration.	 In	 order	 to	more	 closely	 replicate	 the	 in	 vivo	
situation,	inductive	factors	have	been	more	gradually	delivered	using	drug-eluting	scaffolds	or	
gene	therapy.	Still,	 further	 research	needs	 to	study	efficacy	and	spatiotemporal	kinetics	of	
future	 delivery	 systems	 as	 well	 as	 safety	 and	 reliability	 of	 gene	 therapy.	 Recently,	 the	












For	 translation	 toward	 clinical	 application	 of	 cell-based	 cartilage	 repair,	 it	 is	 important	 to	
provide	an	one-step	surgical	procedure	rather	than	multistage	surgery.	Such	a	procedure	aims	
to	generate	a	tissue-engineered	construct	intraoperatively,	prohibiting	the	need	for	 in-vitro	







head	and	neck	 area	 and	has	potential	 to	overcome	 limitations	of	 current	 treatments.	 The	
primary	objective	of	this	thesis	is	to	ultimately	improve	cartilage	regeneration	and	develop	an	
one-step	surgical	therapy	for	the	repair	of	facial	cartilage	defects.	Therefore,	I	focus	on	the	
















For	successful	cell-based	cartilage	repair	 in	 the	head	and	neck	area,	 selection	of	an	
appropriate	 cell	 source	 is	 crucial.	 In	 chapter	 four,	 the	 performance	 of	 culture-expanded	
chondrocytes	and	MSCs	 from	several	anatomical	 locations	 (i.e.	 chondrocytes	derived	 from	
ear,	nose	and	joint,	and	MSCs	derived	from	adipose	tissue	and	bone	marrow)	is	evaluated.	
Culture-expansion	 has	 however	 certain	 disadvantages:	 (1)	 it	 results	 in	 chondrocyte	
dedifferentiation,	 which	 usually	 results	 in	 fibrous	 and	 mechanically	 inferior	 cartilaginous	
tissue;	(2)	it	requires	a	two-step	surgical	procedure.	As	the	basic	principle	for	the	development	





For	 successful	 cartilage	 regeneration,	 the	 properties	 of	 the	 3D	 scaffold	 are	 of	
equivalent	 importance.	 Scaffold	 design	 should	 herein	 substitute	 for	 the	 cell	 natural	
environment	 providing	 instantaneous	 cell	 support	 and	 guiding	 tissue	 development	 and	
remodelling.	Intuitively,	native	ECM	has	the	potential	to	be	the	most	ideal	scaffold	for	tissue	
engineering	and	regenerative	therapies.	Preservation	of	native	ECM	is	best	retained	through	
the	 process	 of	 decellularization.	 Chapter	 seven	 displays	 the	 preparation	 of	 decellularized	






tissue	 regeneration	 and	 homeostasis.	 However,	 it	 appears	 to	 have	 inferior	 mechanical	
properties	 compared	 to	 native	 cartilage.	 Therefore	 a	 novel	 bilayer	 bacterial-nanocellulose	


















Mechanical	 and	 biochemical	 mapping	 of	 human	
















of	 DNA;	 sulfated-glycosaminoglycan,	 sGAG;	 hydroxyproline;	 elastin)	 of	 fresh	 human	 ear	
cartilage	were	evaluated.	Samples	were	categorized	into	age	groups	and	according	to	their	
harvesting	region	in	the	human	auricle	(for	ear	cartilage	only).	
Ear	 cartilage	 displayed	 significantly	 lower	 Ein,	 σmax,	 Eeq,	 sGAG	 content;	 and	
significantly	higher	t1/2,	and	DNA	content	than	nasal	cartilage.	Large	amounts	of	elastin	were	
measured	in	ear	cartilage	(>15%	elastin	content	per	sample	wet	mass).	No	effect	of	gender	
was	 observed	 for	 either	 ear	 or	 nasoseptal	 samples.	 For	 auricular	 samples,	 significant	
differences	 between	 age	 groups	 for	 h,	 sGAG	 and	 hydroxyproline,	 and	 significant	 regional	
variations	 for	 Ein,	 σmax,	 Eeq,	 t1/2,	 h,	 DNA	 and	 sGAG	 were	 measured.	 However,	 only	 low	
correlations	between	mechanical	and	biochemical	parameters	were	seen	(R<0.44).	
In	 conclusion,	 this	 study	 established	 the	 first	 comprehensive	 mechanical	 and	
biochemical	map	of	human	ear	cartilage.	Regional	variations	in	mechanical	and	biochemical	
properties	 were	 demonstrated	 in	 the	 auricle.	 This	 finding	 highlights	 the	 importance	 of	





Surgical	 reconstruction	with	autologous	cartilage	or	alloplastic	 implants	 is	 the	only	existing	
treatment	 for	 auricular	 defects.	 The	 current	 gold-standard	 technique	 -	 autologous	 ear	
reconstruction	[120]	-	is	a	multi-staged	time-consuming	procedure	[9,	121],	that	ranks	among	











structure-function	 relationship	 linking	 composition	 and	 architecture	 to	 mechanical	
competency	has	been	established	 for	 these	 cartilage	 subtypes.	 [140,	 142]	 The	mechanical	










In	 light	of	 this,	 the	aim	of	 this	work	 is	 to	establish	a	mechanical	characterization	of	
native	 human	 ear	 cartilage	 in	 order	 to	 set	 a	 benchmark	 against	 which	 to	 evaluate	 TE	
constructs.	Mechanical	and	biochemical	properties	of	fresh	ear	cartilage	are	determined	and	
compared	 to	 hyaline	 nasoseptal	 cartilage.	 Additionally	 spatial	 variation	 in	 mechanical	











Medical	 Center	 (Rotterdam,	 the	Netherlands,	n=11)	 according	 to	 ethical	 guidelines	 of	 the	
respective	institution.	Additionally	ear	(EC)	and	nasoseptal	(NC)	cartilage	was	obtained	from	






adult,	 ≥50).	 [152]	 All	 samples	 were	 shipped	 at	 4°C	 in	 phosphate	 buffered	 saline	 (PBS)	
supplemented	with	antibiotic/antimycotic	(Gibco,	Invitrogen	Corporation,	California,	USA)	to	




















indenter	 (0.35	 mm).	 During	 testing	 samples	 were	 immersed	 in	 PBS	 supplemented	 with	






relaxation	 half	 life	 time	 (t1/2)	 were	 determined.	 To	 estimate	 viscoelastic	 relaxation,	 t1/2	 is	




Following	 mechanical	 testing,	 each	 sample	 was	 cut	 into	 two	 and	 frozen	 at	 -80°C	 until	
processing.	Samples	were	defrosted,	and	wet	weight	of	each	half	was	measured.	One	half	was	
digested	overnight	at	60°C	with	papain	buffer	 (0.2	M	NaH2PO4,	0.01	M	EDTA,	pH	6.0	and	




















of	 12	 M	 HCL	 at	 95°C	 for	 18–20	 hours.	 Hydroxyproline	 content	 was	 measured	 using	 a	





Elastin	 content	 (EC:	 n=48)	 was	 measured	 using	 the	 Fastin	 Elastin	 Assay	 (Biocolor,	
















age	 group	 and	 harvesting	 location	 were	 fixed	 effects,	 was	 used	 to	 analyze	 statistical	
differences	 between	 mechanical	 (Ein,	 σmax,	 Eeq,	 t1/2)	 and	 biochemical	 (DNA,	 sGAG,	
hydroxyproline)	results.	Additionally	bivariate,	correlation	analyses	between	mechanical	and	







Results	show	that	subtype	 (EC	or	NC)	 is	significantly	different	 for	all	measured	values	 (Ein,	
σmax,	Eeq,	t1/2,	DNA,	sGAG),	except	hydroxyproline.	(Figure	2)	Measured	values	of	Ein,	σmax,	
Eeq,	t1/2,	DNA,	sGAG	and	hydroxyproline	showed	no	significant	differences	between	male	and	
female	 sex	 for	 both	 EC	 and	NC.	 All	male	 and	 female	 data	 points	were	 pooled	 for	 further	
analysis.	
	 Due	to	the	limited	number	of	EC	samples	available	in	child	and	middle	adult	groups,	
only	 young	 adult	 and	 old	 adult	 groups	 were	 used	 to	 investigate	 age	 differences.	 Results	






	 Ein	 σmax	 Eeq	 t1/2	 h	 DNA	 sGAG	 HYP	 ELN	
	 	 	 	 	 	 	 	 	 	
Harvesting	location	 ●	 ●	 ●	 ●	 ●	 ●	 ●	 	 	










and	Eeq	 (Figure	3A,B,C),	where	the	helix	 (HE)	values	were	 lowest,	and	the	anti-tragus	 (AT)	







































































































R	 	 h	 DNA	 sGAG	 HYP	 ELN	
	 	 	 	 	 	 	
EC	 Ein	 0.55●	 -0.23●	 0.31●	 0.16●	 0.39●	
	 σmax	 0.61●	 -0.25●	 0.26●	 -0.10●	 0.44●	
	 Eeq	 0.54●	 -0.27●	 0.32●	 -0.10●	 0.44●	
	 t1/2	 0.10●	 -0.24●	 -0.11●	 -0.02●	 -0.17●●	
	 	 	 	 	 	 	
NC	 Ein	 0.48●	 -0.31●	 0.05	 -0.03●	 -	
	 σmax	 0.63●	 -0.33●	 0.07	 -0.12●	 -	
	 Eeq	 0.44●	 -0.25●	 0.04	 -0.09●	 -	



























grafting,	 and	 cartilage	 donations	 come	 from	 the	 nasal	 septum,	 auricle	 and	 rib.	 Surgically,	
clinicians	or	surgeons	are	looking	for	a	material	where	the	decision	whether	the	graft	qualifies	
for	 implant	 is	 usually	 made	 by	 palpation;	 i.e.	 compressive	 stiffness.	 Bending	 and	 tensile	
properties	would	be	more	reflective	of	functional	material	properties,	but	also	require	large	
sample	dimensions.	With	growing	interest	in	TE	materials,	the	primary	interest	was	to	obtain	
a	 benchmark	 of	 mechanical	 performance	 against	 which	 to	 evaluate	 TE	 strategies,	 and	
therefore,	a	stress-relaxation	indentation	and	biochemical	map	of	human	native	ear	cartilage	
is	presented.	
	 Ear	 cartilage	 has	 significantly	 lower	 strength,	 stiffness	 and	 sGAG	 content;	 and	
significantly	higher	relaxation	time	and	DNA	content	compared	to	nasoseptal	cartilage.	Ear	
cartilage	also	contains	>15%	elastin	content	per	sample	wet	mass;	and	significant	differences	
between	 age	 groups	 were	 observed	 for	 thickness	 and	 matrix	 components	 (sGAG	 and	
hydroxyproline),	 and	 significant	 regional	 variations	 were	 observed	 for	 all	 mechanical	
parameters,	DNA	and	sGAG	content.	Relatively	large	Eeq	values	(10–15	MPa)	were	measured	
for	nasoseptal	cartilage	compared	to	typical	values	reported	in	literature	for	articular	cartilage	




	 Stress-relaxation	 indentation	 is	 able	 to	 capture	 both	 instantaneous	 (Ein)	 and	
equilibrium	behavior	(Eeq)	of	cartilage.	[159]	In	literature,	reports	of	quantitative	mechanics	





















dissipation	 of	 strain	 energy,	 and	 differences	 in	 architecture	 and	 composition.	 [143]	 The	
presence	of	elastin	is	most	likely	responsible	for	these	differences.	
	 Differences	 in	 post-maturity	 growth	 rate	 of	 the	 auricle	 between	 male	 and	 female	




	 Within	 ear	 cartilage	 samples,	 significant	 age-related	 differences	 were	 identified.	
Increasing	h	with	age	was	observed	while	sGAG	and	hydroxyproline	contents	decreased.	Age-
related	 augmentation	 of	 tissue	 thickness	 is	 consistent	with	 previous	 reports	 of	 continued	
growth	of	the	auricle	during	adult	life.	[163-165]	This	is	likely	due	to	altered	quality	of	the	fiber	
network,	specifically	elastic	fibers	become	increasingly	fragmented	and	heterogeneous	with	











variations,	 with	 correlative	 trends	 to	mechanical	 parameters.	 No	 regional	 variations	were	
observed	for	hydroxyproline	and	elastin	content.	This	suggests	that	unlike	hyaline	cartilage,	
an	 altered	 mechanical–chemical–architectural	 relationship	 exists	 in	 elastic	 cartilage,	 and	
tissue	composition	alone	cannot	fully	explain	local	mechanics.	Literature	on	hyaline	cartilage	
[158,	 159,	 162,	 169-175]	 supports	 the	 idea	 that	 ear	 cartilage	 mechanics	 are	 linked	 to	
architecture	and	composition.	Functionally,	specific	local	mechanical	properties	are	necessary	
for	three	dimensional	structure.	The	human	auricle	has	large	vestigial	musculature	anchoring	
the	 head	 (extrinsic)	 and	 connecting	 regions	 of	 the	 auricle	 (intrinsic).	 [122]	 Local	 variation	
highlights	 the	need	 for	TE	strategies	aimed	at	producing	scaffolds	and	grafts	with	spatially	
tunable	mechanics.	[155]	However	since	these	differences	are	quite	small	it	may	also	be	worth	
investigating	whether	 thickness	 variation	 is	 sufficient	 to	provide	 the	necessary	mechanical	
integrity	in	TE	constructs.	
	 Significant	 correlations,	despite	weak	Pearson	coefficients,	were	observed	between	
biochemical	 and	 mechanical	 parameters.	 sGAG	 content	 has	 been	 linked	 to	 mechanical	
behavior	 in	articular	 cartilage	 [162],	while	DNA	content	does	not.	Nonetheless,	higher	 cell	
density	implies	that	extracellular	matrix	occupies	a	lower	volume	fraction,	and	assuming	that	








0.7,	p<0.05,	Table	2),	 sample	and	 indenter	geometries	were	used	which	 limit	 their	bias	on	
measured	properties.	[177]	The	test	setup	could	additionally	be	modeled	using	an	appropriate	
finite	 element	 approach.	 Since	 ear	 cartilage	 displays	 a	 different	 tissue	 composition	 and	
architecture	 to	 articular	 cartilage,	 it	 cannot	 be	 assumed	 that	 models	 used	 for	 articular	
cartilage	would	yield	relevant	results	for	ear	cartilage.	Only	very	recently,	a	first	model	has	
been	proposed	for	ear	cartilage.	[24]	
	 Furthermore,	 tests	were	performed	at	 room	 (20°C)	 rather	 than	physiological	 (37°C)	
temperature.	Literature	indicates	no	change	in	mechanical	properties	for	articular	cartilage	
between	20°C	and	37°C	[178],	and	room	temperature	is	routinely	used	[179].	
	 Although	numerous	attempts	 to	develop	 tissue-engineered	ear	 cartilage	have	been	
reported,	nearly	no	data	is	available	on	the	native	mechanical	properties.	One	reason	is	likely	
the	difficulty	accessing	fresh	tissue.	Although	samples	obtained	for	this	work	were	collected	




	 In	 conclusion,	 this	 study	 establishes	 the	 first	 mechanical	 and	 biochemical	 map	 of	
human	ear	 cartilage,	enabling	 reliable	assessment	of	engineered	ear	 cartilage	 sufficient	 to	
sustain	daily	loading,	while	also	ensuring	cartilage	grafts	are	not	stiffer	than	necessary.	The	
extensive	 elastic	 fiber	 network	 of	 ear	 cartilage	 is	 a	 key	 functional	 component.	 Regional	
variations	are	demonstrated,	and	biochemical	composition	alone	does	not	fully	account	for	
observed	mechanical	variation	indicating	a	probable	contribution	from	local	architecture.	It	


















































































































































































































































































































































































































































































































































































































































































































































































































Cartilage	 samples	 were	 harvested	 from	 cadaveric	 donors	 (n=10).	 Each	 sample	was	
indented	 10	 times	 with	 a	 nano-indentor	 to	 determine	 the	 effective	 Young´s	 modulus.	




Significant	 differences	 were	 seen	 in	 stiffness	 between	 ear	 and	 septal	 cartilage	
(p=0.011),	and	ala	nasi	and	septal	cartilage	(p=0.005).	Elastin	content	was	significantly	higher	




















reconstruction	 but	 the	 availability	 of	 material	 for	 transplantation	 is	 generally	 limited	 and	
donor	site	morbidity	remains	a	risk.	This	is	especially	the	case	in	burn	patients	who	often	suffer	
from	extensive	damage	to	the	nose	and	ears	due	to	their	protruded	position	and	thin	skin	







differences	 in	 composition	 and	 structure	 between	 the	 various	 facial	 cartilage	 types,	 in	
particular	the	ear,	alar	and	septal	cartilage.		
Although	 they	 share	 a	 common	 embryonic	 origin,	 facial	 cartilage	 soon	 differentiates	 into	
distinct	cartilage	subtypes	according	to	their	specific	structural	function.	In	the	early	stage	of	

















to	 the	 mechanical	 function	 of	 cartilage.	 Standard	 biochemistry	 assays	 can	 be	 used	 to	
determine	 the	 concentration	 of	 the	main	 tissue	 components.	 In	 order	 to	 visualise	 the	 3D	
  
structure	of	 the	ECM,	multiple-photon	 laser	 scanning	microscopy	has	been	used	 for	other	
tissues	such	as	articular	cartilage.	[190]	This	method	is	capable	of	revealing	essential	matrix	
components	 i.e.	 chondrocytes,	 collagen	 and	 elastin	 fibers,	 label-free,	 with	 sub-cellular	
resolution	and	deep	penetration.	[191]	
The	reported	stiffness	of	facial	cartilage	types	varies	considerably.	Because	different	
techniques	are	used	 to	measure	 the	cartilage	 it	 is	difficult	 to	give	a	general	value.	Besides	
tensile	or	indentation	measurements	having	different	limitations	and	advantages	[192],	it	is	






influence	 on	 the	 behaviour	 of	 cells	 [196]	 and	 as	 such	 are	 fundamental	 to	 adequate	
regeneration	 of	 cartilage	 [158].	 Therefore,	 insight	 in	 the	 local	 mechanical	 properties	 and	
structure	on	the	ECM	level	is	required	to	provide	the	right	environment	for	cell	differentiation.	
The	device	used	 in	 this	 study	 allows	 indentation	on	 the	micrometre	 scale	 at	 higher	depth	
ranges	providing	essential	mechanical	information	on	the	different	cartilage	subtypes.		
Understanding	the	fundamentals	of	tissue	structures	is	essential	for	adequate	tissue	
engineering.	 From	 practice,	 surgeons	 are	 familiarized	 with	 the	 gross	 mechanical	 traits	 of	
cartilage	in	reconstructive	surgery.	Mechanical	behaviour	however	is	essentially	determined	
on	 the	 microscopic	 scale	 through	 an	 intricate	 symbiosis	 of	 cells	 and	 their	 surrounding	
structures.	 In	 this	 paper,	 we	 aim	 to	 provide	 fundamental	 information	 on	 the	 differences	
between	the	facial	cartilage	types	on	a	structural	and	mechanical	level	with	the	use	of	novel	
technology	to	evaluate	these	parameters	on	the	ECM	level.	Although	without	direct	practical	
implications,	 it	 may	 also	 offer	 surgeons	 new	 insights	 and	 inspiration	 in	 optimizing	 their	












according	 to	 the	ethical	guidelines	of	 the	 institution.	From	each	donor	2	adjacent	samples	
from	the	ear	concha,	medial	nasoseptal	cartilage	and	lateral	alar	cartilage	were	removed	with	
a	 4	 mm	 biopsy	 puncher.	 The	 samples	 were	 shipped	 at	 -20°C	 to	 either	 the	 VUmc	 (Vrije	
Universiteit	Medical	Center,	Amsterdam,	the	Netherlands)	for	biomechanical	and	microscopic	
evaluation	or	EMC	 (Erasmus	Medical	Center,	Rotterdam,	 the	Netherlands)	 for	biochemical	




To	 determine	 mechanical	 properties	 indentation	 measurements	 were	 performed	 using	 a	
novel	 commercial	 nano-indenter	 (Piuma,	Optics11,	 the	Netherlands).	 The	 device	 utilizes	 a	
ferrule-top	 cantilever	 probe	 [197]	 to	 apply	 load	 and	 simultaneously	 measure	 indentation	
depth	using	a	fiber	optic	based	readout.	(Figure	1A	and	C)	In	this	set	up	a	78	µm	diameter	





(Figure	 1B)	were	 analysed	 using	 the	mathematic	model	 derived	 by	Oliver	 and	 Pharr	 for	 a	
spherical	 indenter	 to	determine	 the	effective	Young´s	modulus	 (E*).	 [198]	The	 indentation	





























Structural	 information	 of	 the	 cartilage	 was	 obtained	 by	 Multiple-photon	 laser	 scanning	
microscopy	 using	 intrinsic	 optical	 signals	 from	 unprocessed	 cartilage.	 The	 imaging	 setup	








pair	 of	 galvo	 mirrors.	 Depth	 scanning	 was	 accomplished	 by	 moving	 the	 objective	 with	 a	
stepper	motor.	
The	 second	 harmonic	 (SHG)	 and	 two-photon	 fluorescence	 (2PF)	 photons	 were	
generated	 by	 collagen	 (SHG,	 2PF)	 and	 elastin	 (2PF)	 fibers	 as	well	 as	 by	 intracellular	 auto-
fluorescent	 proteins	 and	were	 collected	 in	 the	 epi-detection	 geometry.	 The	 SHG	 and	 2PF	





Data	 acquisition	 was	 performed	 with	 the	 TriMScope	 I	 software	 (“Imspector	 Pro”),	






Biochemical	 differences	 were	 analysed	 using	 Mixed	 Models	 with	 Bonferroni	 correction.	
Differences	 in	 effective	 Young’s	 modulus	 between	 groups	 were	 determined	 through	


















































































Young’s	modulus	 DNA	 sGAG	 COL	 ELN	
	 	 	 	 	 	
Ear	 R	 0.040	 -0.302	 0.080	 0.096	
	 p	 0.913	 0.396	 0.826	 0.838	
	 n	 10	 10	 10	 7	
	 	 	 	 	 	
Ala	nasi	 R	 -0.427	 0.327	 -0.549	 -0.217	
	 p	 0.219	 0.357	 0.100	 0.641	
	 n	 10	 10	 10	 7	
	 	 	 	 	 	
Septum	 R	 0.405	 0.105	 0.408	 -0.951●	
	 p	 0.246	 0.774	 0.242	 0.049	
















To	our	 knowledge	 this	 is	 the	 first	 study	 that	 compares	 the	biochemical,	 3D	 structural	 and	
mechanical	differences	between	all	three	facial	cartilage	types	in	human	donors.	By	measuring	
differences	 in	cartilage	composition,	structure,	and	stiffness	on	the	ECM	level	we	aimed	to	
identify	 significant	 aspects	 of	 facial	 cartilage	 architecture	 necessary	 for	 adequate	 tissue	
engineering.	



















mechanical	 behaviour	 of	 cartilage.	 They	 found	 different	 viscoelastic	 behaviours	 of	 bovine	
hyaline	 articular	 cartilage	 and	 ear	 cartilage,	with	 ear	 cartilage	 being	more	 elastic	whereas	
articular	cartilage	demonstrated	a	higher	resistance	to	instantaneous	loading.	Upon	enzymatic	
treatment	 to	 remove	 elastin	 and/or	 sGAG,	 they	 demonstrated	 that	 the	 compressive	
mechanical	properties	of	ear	cartilage	appeared	to	be	mainly	due	to	the	elastin	fiber	network	
whereas	 these	 properties	 were	 provided	 by	 collagen	 in	 articular	 cartilage.	Moreover,	 the	
influence	of	sGAG	on	mechanical	behaviour	appeared	different	between	the	cartilage	types:	
in	ear	cartilage	sGAG	had	no	major	influence	on	mechanics	whereas	in	articular	cartilage	sGAG	












different	 between	 ala	 nasi	 and	 septum	 cartilage.	 Sample	 size	 was	 small	 however	 and	 no	
statistical	evidence	was	gathered	to	support	this	side	finding.	
Donor	variability	is	large	and	general	comparison	of	our	data	with	literature	is	difficult	












We	 used	 cartilage	 samples	 from	 donors	 at	 higher	 age	 (average	 66.5	 ±	 6	 years).	
Mechanical	behaviour	and	histology	might	differ	in	younger	patients	due	to	calcifications	and	
structural	changes	during	aging.	Ears	for	example	continue	to	expand	in	volume	throughout	a	
lifetime	which	 is	 attributed	 to	 alterations	 in	 the	 elastic	 fibers	 during	 aging.	 [164]	 For	 the	
septum	however	Richmon	and	colleagues	[26]	found	no	significant	differences	in	mechanical	
properties	between	age	or	gender.	Although	samples	were	taken	from	the	same	anatomical	
location	 in	 all	 donors,	minor	 variation	might	have	occurred.	 This	 is	 a	 limitation,	 as	 several	





to	 explore	 the	 stiffness	 of	 the	 ECM,	 in	 regard	 of	 our	 findings	 perhaps	 a	 combination	 of	
mechanical	tests	is	necessary	to	be	able	to	elicit	the	different	structural	roles	of	the	various	









metabolism,	 as	 cell	 survival	 and	 behaviour	 are	 key	 to	 tissue	 engineering	 and	 long-term	







In	 conclusion,	 understanding	 the	 complete	 composition	 of	 tissue,	 both	 structural,	
mechanical	and	biochemical,	 is	essential	 in	order	 to	 regenerate	an	appropriate	 scaffolding	
environment	for	facial	cartilage	regeneration.	This	is	particularly	reflected	by	the	finding	that	
albeit	it’s	3D	structural	similarity	to	septal	cartilage,	the	ala	nasi	has	a	matrix	stiffness	that	is	
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The	 in	 vitro	 and	 in	 vivo	 capacity	of	 culture-expanded	










Cartilage	 has	 limited	 self-regenerative	 capacity.	 Tissue	 engineering	 can	 offer	 promising	
solutions	for	reconstruction	of	missing	or	damaged	cartilage.	A	major	challenge	herein	is	to	
define	an	appropriate	cell	source	that	is	capable	of	generating	a	stable	and	functional	matrix.	
This	 study	evaluated	 the	performance	of	culture-expanded	human	chondrocytes	 from	ear,	
nose	 and	 articular	 joint	 as	 well	 as	 bone-marrow-derived	 and	 adipose-tissue-derived	
mesenchymal	stem	cells	both	in	vitro	and	in	vivo.		
All	 cells	 (at	 least	 three	donors	per	 source)	were	 culture-expanded,	 encapsulated	 in	
alginate	 and	 cultured	 for	 five	 weeks.	 Subsequently,	 constructs	 were	 implanted	
subcutaneously	for	eight	additional	weeks.	Before	and	after	implantation,	glycosaminoglycan	
(sGAG)	and	collagen	content	were	measured	using	biochemical	assays.	Mechanical	properties	
were	 determined	 using	 stress-strain-indentation	 tests.	 Hypertrophic	 differentiation	 was	
evaluated	with	qRT-PCR	and	subsequent	endochondral	ossification	with	histology.		
Articular	chondrocytes	had	higher	chondrogenic	potential	in	vitro	than	the	other	cell	
sources,	 as	 assessed	 by	 gene-expression	 and	 sGAG-content	 (p<0.001).	 However,	 after	
implantation,	articular	chondrocytes	did	not	further	increase	their	matrix.	In	contrast,	ear	and	
nasal	 chondrocytes	 continued	 producing	 matrix	 in	 vivo	 leading	 to	 higher	 sGAG-content	
(p<0.001)	 and	 elastic	 modulus.	 For	 constructs	 containing	 nasal	 chondrocytes,	 matrix-
deposition	was	associated	with	the	elastic	modulus	(R2=0.477,	p=0.039).	Although	all	cells	-	











locations	 such	 as	 the	 ear,	 nose,	 trachea,	 ribs	 and	 articular	 joints.	 In	 general,	 cartilage	
predominantly	consists	of	an	extracellular	matrix	(ECM),	which	is	produced,	maintained	and	
remodeled	 by	 a	 relatively	 small	 amount	 of	 specialized	 cells	 (1-10%).	 [34]	 The	 exact	
composition	of	the	ECM	is	mainly	dependent	on	the	tissue’s	function	and	thus	three	major	
subtypes	can	be	distinguished:	hyaline,	fibrous	and	elastic	cartilage.	It	is	well	known	that	due	
to	 its	 avascular	 origin,	 cartilage	 itself	 has	 a	 limited	 self-regenerative	 capacity.	 As	 a	 result,	
cartilage	 deficits	 can	 lead	 to	 severe	 pain,	 disability	 and	 aesthetic	 impairment.	 Currently,	
surgical	 repair	 of	 cartilage	 requires	 either	 autogeneic	 cartilage	 grafts	 or	 artificial	 material	




restoring	missing	or	damaged	 cartilage.	 TE-approaches	have	 focused	on	 the	production	of	






cartilage	 is	most	 frequently	 used	 for	 cartilage	 TE,	 although	 some	 experiments	 have	 been	
published	on	the	use	of	non-articular	cartilages	(e.g.	nasal,	ear	and	costal	cartilage).	[205]	Next	









and	 in	 vivo.	 Therefore,	 human	 chondrocytes	 from	 ear,	 nose	 and	 articular	 joint	 and	MSCs	
derived	from	bone	marrow	and	adipose	tissue	were	compared.	Cartilage	matrix	production	
was	 evaluated	 using	 qRT-PCR	 and	 biochemical	 assays	 during	 in	 vitro	 culture.	 Biochemical	









range	 18-46	 years)	 were	 obtained	 from	 patients	 undergoing	 reconstructive	 subtotal	
septorhinoplasty.	For	articular	cartilage	(AC),	both	healthy	(n=2,	traumatic	amputation)	and	
diseased	 knee	 cartilage	 (n=7,	 osteoarthritis)	were	 harvested.	 Since	 no	 clear	 differences	 in	
chondrogenic	potential	were	visible	between	both	healthy	and	diseased	AC	(data	not	shown),	
we	combined	them	for	further	experiments	(total	n=9,	median	age	68,	range	43-88	years).	To	











To	 isolate	 chondrocytes,	macroscopically	 intact	 cartilage	pieces	were	washed	after	 careful	
resection	of	the	perichondrium	(in	the	case	of	nasal	and	ear	cartilage).	Cartilage	pieces	were	
diced	into	small	fragments	and	incubated	for	one	hour	with	protease	(2	mg/mL),	followed	by	





















separated	 from	 the	 precipitating	MSC	 fraction	 by	 centrifugation	 (10	minutes,	 1500	 RPM),	
washed	with	‘standard	MSC	expansion	medium’,	and	filtered	through	a	100-μm	nylon	mesh.	
Before	cell	seeding,	the	amount	of	nucleated	cells	was	calculated	using	methylene	blue,	and	



























pyruvate	 (Gibco);	 40	 μg/mL	 L-proline	 (Sigma-Aldrich);	 supplemented	 Insulin	 Transferrine	
Selenium	 (ITS+	 ;	 B&D	 Bioscience,	 Bedford,	 USA);	 10-7	M	 dexamethason;	 and	 25	 μg/mL	 L-
ascorbic	 acid	 2-phosphate.	 In	 the	 experimental	 condition	 (‘chondrogenic	 differentiation	
medium’)	10	ng/mL	Transforming	Growth	Factor	β1	(TGFβ1;	R&D	Systems,	Minneapolis,	USA)	
was	added	to	induce	chondrogenesis.	Medium	was	changed	twice	a	week.	After	two	and	five	






















constructs	were	 randomly	assigned	 to	 these	 four	pockets.	Eight	weeks	after	 subcutaneous	








8	 minutes.	 Each	 pellet	 was	 subsequently	 suspended	 in	 1	 mL	 RNA-BeeTM	 (TEL-TEST,	
Fiendswood,	USA).	RNA	was	extracted	with	 chloroform	and	purified	 from	 the	 supernatant	
using	 the	 RNAeasy	 Micro	 Kit	 (Qiagen,	 Hilden,	 Germany)	 according	 to	 the	 manufacturer’s	
guidelines	by	on-column	DNA-digestion.	Extracted	total	RNA	was	quantified	using	NanoDrop®	










Phosphate	 DeHydrogenase	 (GAPDH),	 and	 Hypoxanthine	 PhosphoRibosylTransferase	 1	
(HPRT1)	were	used	as	housekeeping	genes.	The	expression	of	GAPDH	and	HPRT1	did	not	differ	
between	cell	sources	and	both	were	used	to	calculate	the	best	housekeeper	index.	[211]	Using	
repeated	 pair-wise	 correlation	 analysis,	 data	 were	 normalized	 by	 calculating	 the	 ‘best	
housekeeper	 index’.	 (Data	 not	 shown)	 Polymerase	 Chain	 Reactions	were	 performed	 using	
  
TaqMan®	Universal	PCR	Mastermix	 (Applied	Biosystems)	or	qPCR	Mastermix	Plus	 for	SYBR	
Green	 (Eurogentec,	 Nederland	 BV,	 Maastricht,	 the	 Netherlands)	 according	 to	 the	
manufacturers’	 guidelines	 and	 using	 an	 ABIPRISM®	 7000	 with	 SDS	 software	 version	 1.7	
(Applied	Biosystems,	Nieuwerkerk	a/d	IJssel,	the	Netherlands).	Amplification	efficiencies	for	

























































Samples	were	 then	 dried	 and	 redissolved	 in	 150	 µL	water.	 Hydroxyproline	 contents	were	














anti-mouse	 biotin	 at	 4oC	 (Jackson	 Laboratories,	 Bar	Harbor,	USA),	 followed	by	 a	 two-hour	
incubation	 in	 0.1%	 normal	 mouse	 serum	 (CLB,	 Amsterdam,	 the	 Netherlands)	 in	 order	 to	
capture	the	unbound	second	antibody.		
Antigen	 retrieval	 for	 the	 collagen	 type	 II	 (Developmental	 Studies	 Hybridoma	 Bank,	





or	elastin	 (1:1000)	 for	60	minutes.	Sections	were	than	 incubated	with	enzyme-streptavidin	
conjugate	(Label,	1:100,	Biogenex,	HK-321-UK,	California,	USA)	 in	PBS/1%	BSA,	 followed	by	











V6630).	 Thereafter,	 the	 MM-polymer-HRP®	 secondary	 antibody	 was	 used,	 succeeded	 by	
incubation	with	3’diaminobenzidine	chromogen	solution.	Tissue	specificity	was	confirmed	by	

















uniformity	 and/or	 intensity	 of	 the	 Thionin	 and	 collagen	 type	 II	 staining;	 (2)	 the	 distance	
between	 cells	 and	 the	 extent	 of	 matrix	 produced;	 and	 (3)	 the	 cellular	 morphology.	 Each	
category	has	scores	ranging	from	0	to	3,	resulting	in	a	possible	minimum	collective	score	of	0	





































mm	 per	 minute.	 An	 in-house	 Matlab®	 script	 was	 used	 to	 locate	 the	 sample	 surface	 and	







All	 data	were	 analyzed	with	 PASW	Statistics	 20.0	 (SPSS	 inc.	 Chicago,	USA).	 The	mean	 and	
standard	deviations	are	presented.	For	statistical	evaluation,	a	mixed	linear	model	was	used.	
Cell	 source,	 time	point	and	 treatment	 (TGFβ1)	were	defined	as	 fixed	 factors	 in	 the	model.	
Donor	and	sample	number	were	treated	as	random	factors.	Values	of	p<0.05	were	considered	


































After	 cell-expansion,	 cells	 were	 encapsulated	 in	 clinical-grade	 alginate	 to	 promote	
chondrogenesis.	Alginate	beads	cultured	without	TGFβ1	had	maintained	their	DNA	content	
after	five	weeks	of	culture.	Addition	of	TGFβ1	significantly	increased	the	total	amount	of	DNA	




Chondrocytes	 did	 express	 low	 levels	 of	 COL2A1	 and	 ACAN	 without	 TGFβ1.	 After	
chondrogenic	induction	(with	TGFβ1),	the	COL2A1	and	ACAN	gene	expression	levels	increased	
in	all	cell	source	used.	Both	genes	were	most	highly	expressed	by	ACs	(p<0.001),	followed	by	




sGAG-production	 and	 after	 five	 weeks	 of	 culture	 ACs	 deposited	 significantly	 more	 sGAGs	













the	 best	 housekeeper	 index.	 All	 cell	 sources	 expressed	ACAN	 and	COL2A1	 after	 chondrogenic	 induction.	 (C)	
Biochemical	 evaluation	 of	 sGAG	 and	 collagen	 content	 after	 chondrogenic	 induction	 in	 alginate	 beads.	 ACs	









with	 large	 variation	 between	 donors,	 AMSCs	 performed	 worse.	 The	 amount	 of	 collagen	




To	 study	 the	 stability	 and	 quality	 of	 TE	 cartilage	 in	 vivo,	 alginate	 constructs	 were	 first	
differentiated	 in	 vitro	 for	 five	 weeks	 and	 subsequently	 implanted	 subcutaneously	 on	 the	
dorsal	side	of	athymic	mice	for	an	additional	eight	weeks	of	culture.	Constructs	seeded	with	
ECs	or	NCs,	pre-cultured	with	TGFβ1,	had	a	macroscopically	white	opaque	appearance	and	
were	 relatively	 strong	 on	 handling.	 Conversely,	 constructs	 pre-cultured	 without	 TGFβ1	 or	






Macroscopic	 view	 of	 engineered	 cartilage	 constructs	 after	 8	 weeks	 of	 subcutaneous	 implantation.	 (B)	
Biochemical	 evaluation	 of	 the	 sGAG	 and	 collagen	 content	 after	 subcutaneous	 implantation.	 ECs	 and	 NCs	










Prior	 to	 implantation,	 constructs	 pre-cultured	without	 TGFβ1	produced	 very	 little	 sGAG	 in	
vitro,	being	on	average	1,10	±	1,20	µg	sGAG	per	construct.	After	in	vivo	implantation,	these	
constructs	greatly	 increased	their	production	of	matrix	components,	although	they	did	not	













staining	 for	 collagen	 type	 II,	 although	 the	 dissimilar	 distribution	 of	 collagen-type-II	 fibers	
within	 the	 cartilage	 matrices	 were	 apparent.	 The	 semi-quantitative	 histological	 scores	 of	
constructs	containing	ECs	or	NCs	were	significantly	better	than	the	scores	of	the	other	cell	
sources.	(Figure	3C)		
The	 presence	 of	 elastin	 was	 determined	 to	 evaluate	 differentiation	 into	 elastic	
cartilage.	 There	 was	 no	 elastin	 detectable	 in	 any	 of	 the	 constructs	 with	 an	 elastin	
immunostaining	after	five	weeks	of	in-vitro	cell	culture.	(Data	not	shown)	After	subcutaneous	
implantation,	 elastin	 was	 only	 present	 in	 alginate	 constructs	 containing	 ECs,	 and	
predominantly	 found	 in	 constructs	which	were	pre-cultured	with	TGFβ1.	Most	elastin	was	
located	around	the	cell.	(Figure	3D)		
To	ensure	that	these	cartilage	constructs	were	from	human	origin,	a	human-specific	








Macroscopic	 view	 of	 engineered	 cartilage	 constructs	 after	 8	 weeks	 of	 subcutaneous	 implantation.	 (B)	
Biochemical	 evaluation	 of	 the	 sGAG	 and	 collagen	 content	 after	 subcutaneous	 implantation.	 ECs	 and	 NCs	
deposited	most	sGAGs	 in	vivo.	Collagen-production	was	 increased	 in	vivo,	but	did	not	differ	between	the	cell	
sources.	(C)	ECs	and	NCs	demonstrated	a	collagen-type-II-rich	matrix	in	almost	all	cartilage	constructs,	leading	to	








cell	 sources.	 EC	 =	 Ear	 Chondrocytes	 (n=3	 donors)	 ;	 NC	 =	 Nasal	 Chondrocytes	 (n=3	 donors)	 ;	 AC	 =	 Articular	












higher	 in	 constructs	with	BMSCs	 compared	 to	 the	other	 cell	 sources	 (p<0.05).	 In	 addition,	






calcify	 in	vivo.	Also,	calcification	was	more	often	seen	 in	constructs	pre-cultured	 in	control	











matrix	 components,	 a	 multiple	 regression	 analyses	 was	 performed	 for	 all	 cell	 sources	
separately	using	sGAG	and	collagen	deposition	as	independent	variables.	Only	for	constructs	
containing	 NCs,	 matrix	 components	 significantly	 associated	 with	 the	 biomechanical	
functionality	of	the	constructs	(R2=0.477,	F=4.558,	p=0.039).	For	these	constructs,	only	sGAG-






































while	 ear	 chondrocytes	 (ECs)	 and	 nasal	 chondrocytes	 (NCs)	 are	most	 potent	 for	 cartilage	
regeneration	after	subcutaneous	implantation	in	vivo.		
To	date,	we	and	others	have	evaluated	 the	use	of	 chondrocytes	and	mesenchymal	
stem	 cells	 (MSCs)	 of	 several	 anatomical	 locations	 for	 their	 applicability	 in	 cartilage	
regenerative	medicine.	[39,	42-44,	46-59,	206-209]	However,	these	studies	often	used	non-
expanded	 cells	 isolated	 from	 animals.	 Moreover,	 a	 detailed	 direct	 comparison	 between	
various	 chondrocyte	 and	 MSC-sources	 was	 lacking.	 Therefore,	 this	 study	 is	 the	 first	 to	




tissue	 rejection	 response.	However,	 it	has	been	difficult	 to	obtain	appropriate	numbers	of	
cells,	 as	 donor	 tissue	 is	 limited	 and	 harvesting	 can	 cause	 large	 donor	 site	 morbidity.	
Consequently,	 monolayer	 cell-expansion	 has	 become	 an	 essential	 step	 in	 the	 process	 of	
cartilage	TE.	To	fulfil	this	requirement,	we	culture-expanded	all	cells	for	four	passages.	It	was	
obvious	that	different	cells	went	through	a	different	number	of	population	doublings	during	




shown	 that	 expanded	 cells	 can	 regain	 their	 chondrogenic	 potential	 under	 specific	 culture	
conditions:	(1)	the	use	of	a	3D-culture	system	(2)	and/or	the	administration	of	chondrogenic	
factors,	 such	 as	 TGFβ.	 [216]	 In	 order	 to	 generate	 a	 3D-culture	 environment,	 we	 have	
encapsulated	all	 cells	 in	 clinical	 grade	alginate,	 since	 alginate	enables	 a	homogeneous	 cell	
distribution,	prevents	cells	from	floating	out	while	permitting	nutrient	diffusion	and	oxygen	














of	 alginate	 itself.	 Surprisingly	 and	 in	 contrast	 to	 our	 previous	work	with	MSCs	 in	 collagen	
scaffolds	[71]	or	 in	pellets	without	scaffold	[218],	constructs	containing	MSCs	(both	BMSCs	
and	AMSCs)	never	mineralized	 in	vivo,	although	signs	of	endochondral	differentiation	were	
observed	 prior	 to	 implantation.	 The	 absence	 of	 endochondral	 ossification	 during	 in	 vivo	
implantation	was	accompanied	by	 lack	of	neovascularization	or	vessel	 ingrowth	within	 the	
matrix,	which	 is	known	to	be	extremely	 important	 for	endochondral	ossification	[219].	We	
believe	that	alginate	prevented	this	process,	by	the	fact	that	endothelial	cells	lack	receptors	
to	 bind	 to	 alginate	 polymers,	 prohibiting	 neovascularization	 or	 vessel	 ingrowth.	 [220]	
Therefore,	 it	 seemed	 that	 alginate	 could	 be	 an	 excellent	 cell-carrying	 gel	 for	 cartilage	








to	 the	 other	 cell	 sources.	 The	 beneficial	 effect	 of	 culturing	 with	 TGFβ1	 during	 in-vivo	
chondrogenesis	 was	 present,	 although	 less	 obvious.	 Constructs	 cultured	 without	 TGFβ1	
increased	their	production	of	matrix	components	after	in-vivo	implantation,	but	were	not	able	
to	reach	levels	found	in	constructs	cultured	with	TGFβ1.	
Even	 after	 four	 passages	 of	 culture-expansion,	 chondrocytes	 demonstrated	 some	 clear	
subtype	specific	differences.	Firstly,	ACs	possessed	the	highest	chondrogenic	capacity	in	vitro,	
but	were	not	able	 to	 further	 increase	 their	 cartilage	matrix	 in	 vivo.	 The	 inability	of	ACs	 to	
promote	cartilage	formation	in	vivo	may	be	due	to	the	lack	of	mechanical	loading	or	growth	
factor	 stimulation	 after	 subcutaneous	 implantation	 which	 may	 have	 led	 to	 a	 loss	 of	
chondrogenic	capacity.	ACs,	different	from	the	other	cell	sources,	are	exposed	to	mechanical	
loading	within	native	articular	cartilage	and	unloading	is	known	to	induce	sGAG-release	from	





elastin	 in	 vivo	 suggests	 that	 these	 cells	 retain	 their	 capability	 to	 form	 an	 elastic	 cartilage	







MSCs,	 adipose	 tissue	 has	 been	 proven	 to	 be	 an	 attractive	 alternative	 in	 respect	 to	 the	
abundant	and	easily	accessible	pool	of	MSCs.	[67,	68]	We	have	demonstrated	that	both	BMSCs	
  
and	 AMSCs	 underwent	 chondrogenic	 differentiation	 in	 vitro	 and	 in	 vivo,	 although	 matrix	
production	was	less	than	in	constructs	containing	chondrocytes	(ACs,	NCs	or	ECs).	Constructs	
containing	 BMSCs	 had	 a	 higher	 chondrogenic	 potential	 than	 AMSCs,	 demonstrated	 by	 an	
increased	ACAN	and	COL2A1	gene-expression	and	an	 improved	sGAG-deposition.	With	 the	
exception	 of	 a	 few	 studies	 [223-226],	 this	 confirms	 other	 studies	 [55,	 207,	 227-235].	
Nevertheless,	 the	 assumptions	 that	 MSCs	 are	 fundamentally	 less	 chondrogenic	 than	
chondrocytes	and	that	BMSCs	are	more	in	favor	for	cartilage	regeneration	than	AMSCs,	seems	
unjustified.	It	appears	that	cell	culture	conditions	for	both	BMSCs	and	AMSCs	remain	to	be	
improved.	For	 instance,	 it	was	 found	 that	another	member	of	 the	TGFβ-superfamily,	Bone	
Morphogenetic	 Protein	 6,	 is	 obligatory	 to	 improve	 chondrogenic	 differentiation	 in	AMSCs.	
[236]	
Finally,	 in	 order	 to	 understand	 how	 the	 distribution	 and	 composition	 of	 matrix	
components	 resulted	 in	 a	 mechanically	 functional	 cartilage	 matrix,	 the	 compositional	
biomechanical	 relationship	 of	 the	 cartilage	 constructs	 was	 evaluated.	 After	 in-vivo	
implantation,	mechanical	properties	increased	in	constructs	containing	ECs	and	NCs.	Only	for	
constructs	 containing	 NCs,	 matrix	 components	 were	 significantly	 correlated	 to	 their	
biomechanical	 functionality.	 It	 is	 already	 known	 that	 sGAGs	 and	 collagens,	 the	 main	





of	 elastin	 to	mechanical	 functionality	 is	 not	 yet	 fully	 understood.	Besides	 the	existence	of	
matrix	components,	the	quality	of	the	matrix	is	not	only	determined	by	the	amount	of	matrix	
components	 deposited,	 but	 also	 influenced	 by	 the	 number	 of	 cross-links	 between	matrix	
molecules	(i.e.	collagen	cross	links).	[238]	The	distribution	of	matrix	components	in	the	ECM	






The	present	 study	has	 certain	 limitations.	 Firstly,	 cell	 density	plays	 a	 critical	 role	 in	
functional	 and	 stable	 cartilage	 formation.	 Others	 have	 demonstrated	 that	 cell	 densities	




have	culture-expanded	all	cells	until	passage	 four	 to	obtain	a	sufficient	number	of	cells.	 In	
order	to	be	able	to	compare	all	different	cell	sources,	we	have	used	standardized	protocols	
for	 the	 culture-expansion	 of	 both	 chondrocytes	 and	MSCs.	 Differences	 in	 expansion	 rates	




















containing	 nasal	 chondrocytes,	 sGAG	 and	 collagen	 content	 were	 associated	 with	
biomechanical	functionality	of	the	constructs,	indicating	the	differences	in	matrix	component	
assembly	by	different	cell	sources.	The	inability	of	ACs	to	increase	cartilage	matrix	in	vivo	may	
be	due	to	a	 loss	of	chondrogenic	capacity	 in	 the	absence	of	mechanical	 loading	or	growth	





The	 authors	 thank	 the	 Departments	 of	 Orthopaedic	 Surgery,	 Plastic	 and	 Reconstructive	
Surgery,	and	Otorhinolaryngology	at	Erasmus	MC	for	their	assistance	in	obtaining	ear,	nasal	
and	 articular	 cartilage	 as	well	 as	 bone	marrow	 and	 adipose	 tissue,	 and	CellMed	 (Alzenau,	
Germany)	 for	 providing	 the	 clinical	 grade	 alginate.	 The	 study	 was	 performed	 within	 the	







Trophic	 effects	 of	 adipose-tissue-derived	 and	 bone-











Combining	mesenchymal	 stem	 cells	 (MSCs)	 and	 chondrocytes	 has	 great	 potential	 for	 cell-
based	cartilage	repair.	However,	there	is	much	debate	regarding	the	mechanisms	behind	this	





hAMSCs	 or	 hBMSCs	were	 combined	with	 bACs	 in	 alginate	 and	 cultured	 in	 vitro	 or	



















Cartilage	 has	 a	 very	 limited	 capacity	 for	 self-regeneration.	 Untreated	 lesions	 -	 caused	 by	








(1)	 chondrocytes	 or	 (2)	mesenchymal	 stem	 cells	 (MSCs).	 These	 cell-based	 procedures	 are	
however	 associated	 with	 specific	 disadvantages.	 Chondrocytes	 from	 several	 anatomical	
locations	(e.g.	joint,	rib,	nose,	ear,	meniscus)	have	been	investigated	for	their	application	in	
cartilage	 regeneration.	 [39-59]	However,	 to	 generate	 a	 construct	 of	 reasonable	 size,	 large	
numbers	 of	 chondrocytes	 are	 required,	 necessitating	 the	 use	 of	 culture-expansion.	 In	
monolayer	culture-expansion,	chondrocytes	dedifferentiate;	they	change	phenotypically	to	a	
fibroblast-like	 morphology	 and	 lose	 their	 chondrogenic	 gene-expression	 capacity.	
Chondrocyte-dedifferentiation	usually	 results	 in	 fibrous	and	mechanically	 inferior	cartilage,	
making	them	less	suitable	for	cell-based	cartilage	repair.	[61]	In	contrast,	multipotent	cells,	
like	MSCs,	achieved	considerable	attention	as	alternative	cells,	as	they	can	undergo	multiple	
population	doublings	without	 losing	 their	chondrogenic	potential	and	have	 the	capacity	 to	
differentiate	into	cartilage	tissue	under	appropriate	culture	conditions.	[64-68]	Furthermore,	
MSCs	are	easily	 available	 from	several	 tissues,	 including	bone	marrow	and	adipose	 tissue,	
which	makes	culture-expansion	unnecessary.	However,	the	single	use	of	MSCs	for	cell-based	
cartilage	 repair	 is	 currently	 debated,	 since	 the	 cartilage	 tissue	 formed	 is	 unstable	 and	
predisposed	to	mineralization	and	ossification	in	vivo.	[69-71,	240,	241]		















and	tissue	mineralization.	 [75,	81,	242]	 In	contrast,	 three	co-culture	studies	using	adipose-
  
tissue-derived	 MSCs	 (AMSCs)	 showed	 limited	 or	 decreased	 effects	 of	 MSCs	 on	










elucidated.	 Therefore,	 chondrogenesis	 of	 human	 AMSCs	 (hAMSCs)	 and	 BMSCs	 (hBMSCs)	
combined	 with	 bovine	 articular	 chondrocytes	 (bACs)	 is	 compared.	 The	 xenogeneic	 set-up	
using	 hMSCs	 and	 bACs	 will	 allow	 conclusions	 about	 the	 cell	 type	 responsible	 for	
chondrogenesis.	As	cellular	interactions	can	be	influenced	or	overruled	by	exogenous	growth	
factors,	no	growth	factors	are	added	to	the	culture	system	to	study	cartilage	formation	of	the	
co-cultures	 in	 vitro.	 Moreover,	 cartilage	 formation	 will	 be	 evaluated	 after	 immediate	




























incubation	 with	 1.5	 mg/mL	 collagenase	 B	 (Roch	 Diagnostics,	 Germany)	 in	 High	 Glucose	 -	
Dulbecco's	Modified	Eagle's	Medium	(HG-DMEM	;	Gibco)	with	10%	FCS,	50	µg/mL	gentamycin	






For	 in-vitro	 and	 in-vivo	 studies,	 all	 cells	 were	 encapsulated	 in	 alginate	 (Batch	 MG-004,	




Second-passaged	 hMSCs	 and	 non-expanded	 primary	 bACs	 were	 harvested	 and	

































	In	 vitro,	 constructs	 were	 cultured	 in	 ‘basic	 medium’	 containing	 serum-free	 HG-DMEM	
supplemented	 with	 50	 µg/mL	 gentamycin;	 0.5	 µg/mL	 Fungizone;	 1	 mM	 sodium	 pyruvate	
(Gibco);	 40	 μg/mL	 L-proline;	 supplemented	 Insulin	 Transferrine	 Selenium	 (ITS+	 ;	 B&D	








dissection.	 For	 each	 condition	 referred	 to	 in	 table	 1,	 3	 independent	 donors	were	 used	 in	
duplicate	 (total	 n=36).	 Moreover,	 cell-free	 constructs	 were	 used	 as	 controls	 (n=4).	 For	
implantation,	alginate	constructs	were	randomly	assigned	to	these	4	pockets.	After	8	weeks,	
animals	 were	 sacrificed	 and	 samples	 were	 explanted	 for	 histological,	 biomechanical	 and	
biochemical	analyses.	Animal	experiments	were	carried	out	to	the	guidelines	prescribed	by	
the	Dutch	National	Institutes	of	Health,	and	were	approved	by	the	Dutch	equivalent	of	the	




	 Source	 Cell	 density	(x106)	 Source	
Cell	 density	
(x106)	
hAMSC	 hAMSCs	 4	nc/mL	 x	 x	
hBMSC	 hBMSCs	 4	nc/mL	 x	 x	
bAC	 x	 x	 bACs	 4	nc/mL	
hAMSC/bAC	 hAMSCs	 3.2	nc/mL	 bACs	 0.8	nc/mL	
hBMSC/bAC	 hBMSCs	 3.2	nc/mL	 bACs	 0.8	nc/mL	





control	 conditions).	 Furthermore,	 hMSCs	 and	 bACs	 were	 co-cultured	 in	 (B)	 a	 Transwell®	
system	as	well	as	in	(C)	medium	conditioned	by	the	other	cell	type,	to	further	understand	the	
























addition	of	Transforming	Growth	Factor	β1	 (TGFβ1	 ;	R&D	Systems,	USA)	 for	24	hours	was	





hMSCs	 and	bACs	were	 suspended	 at	 a	 density	 of	 4x106	 cells/mL	 in	 clinical	 grade	 alginate	
solution	 as	 single-cell-type	 populations	 and	 transferred	 into	 a	 10-mL	 sterile	 syringe.	
Thereafter,	 the	 cell-suspension	was	 slowly	 passed	 through	 a	 23-gauge	 needle	 to	 produce	
drops,	 which	 fell	 into	 a	 102	 mM	 CaCl2	 creating	 alginate	 beads.	 Following	 instantaneous	
gelation,	beads	were	allowed	to	further	gelate	for	a	period	of	10	minutes	in	the	CaCl2-solution.	


















pepstatin	 A	 ;	 pH	 7.6).	 After	 digestion,	 samples	were	 subjected	 to	 biochemical	 analyses	 to	
determine	 DNA,	 sulfated-glycosaminoglycan	 (sGAG),	 and	 hydroxyproline	 contents	 as	
described	previously.	[40]	In	short,	the	amount	of	DNA	was	determined	by	Ethidium	bromide	
(GibcoBR1),	 using	 calf	 thymus	 DNA	 as	 a	 standard.	 sGAGs	 were	 quantified	 by	 the	 1,9-
Dimethylmethylene	blue	(DMMB)	dye-binding	assay,	using	shark	chondroitin	sulphate	C	as	a	
standard.	To	be	suitable	for	cell	cultures	containing	alginate,	the	DMMB-pH-level	was	adjusted	
to	 pH	 1.75,	 as	 described	 previously.	 [212]	 For	 the	 hydroxyproline	 content,	 digests	 were	
hydrolysed,	dried	and	redissolved	in	150	µL	water.	Hydroxyproline	contents	were	measured	
using	chloramine-T	and	dimethylaminobenzaldehyde	as	reagents	and	hydroxyproline	(Merck,	
Germany)	 as	 a	 standard.	 Collagen	 content	 was	 subsequently	 estimated	 from	 the	





fixed	 in	4%	 formalin	 in	PBS	and	embedded	 in	paraffin.	Paraffin-embedded	sections	 (6	μm)	
were	deparaffinised	and	rehydrated.		
To	 evaluate	 tissue	 calcification,	 Von	 Kossa	 staining	 was	 performed.	 Slides	 were	
immersed	in	5%	silver	nitrate	solution	for	10	minutes,	rinsed	in	MilliQ	and	exposed	to	light	for	
another	 10	minutes.	 Excess	 silver	 nitrate	 was	 removed	with	 5%	 sodium-thiosulphate	 and	
slides	were	rinsed	in	distilled	water	afterwards.	Sections	were	counterstained	with	Nuclear	
fast	red	(Merck).	
To	 allow	 the	 use	 of	 monoclonal	 mouse	 antibody	 collagen	 type	 II	 (II-II6B3	 1:100;	
Developmental	Studies	Hybridoma	Bank,	USA)	on	constructs	which	had	been	 implanted	 in	




Antigen	 retrieval	was	 performed	 through	 incubation	with	 0.1%	pronase	 for	 30	minutes	 at	
37oC,	continued	with	a	30	minutes	 incubation	with	1%	hyaluronidase	at	37oC.	Non-specific	












fitting	 Ø	 5	mm	 stainless	 steel	 cylindrical	 wells.	Mechanical	 testing	 was	 performed	 with	 a	
materials	testing	machine	(Zwick	Z005,	Ulm,	Germany)	equipped	with	a	10	N	load	cell,	a	built-
in	displacement	control,	and	a	cylindrical,	plane	ended,	stainless	steel	indenter	(Ø	1.2	mm).	
During	 mechanical	 testing	 the	 samples	 were	 immersed	 in	 PBS.	 Stress-strain	 testing	 was	
performed:	the	samples	were	compressed	to	a	final	height	of	0.5	mm	at	a	loading	rate	of	5	
mm	 per	 minute.	 An	 in-house	 Matlab®	 script	 was	 used	 to	 locate	 the	 sample	 surface	 and	






Ethylene	Diamintetraacetate	 (EDTA)	 in	150	mM	NaCl	and	centrifuged.	Each	 cell-pellet	was	
subsequently	 suspended	 in	1	mL	RNA-BeeTM	 (TEL-TEST,	USA).	 For	 total	RNA	 isolation	 from	
pellets,	pellets	were	manually	homogenized	and	suspended	in	300	μL/pellet	RNA-BeeTM.	RNA	
was	extracted	with	chloroform	and	purified	from	the	supernatant	using	the	RNAeasy	Micro	
Kit	 (Qiagen,	 Germany)	 according	 to	 the	 manufacturer’s	 guidelines	 by	 on-column	 DNA-
digestion.	Extracted	total	RNA	was	quantified	using	NanoDrop®	ND-1000	Spectrophotometer	
(NanoDrop	Technologies,	Wilmington,	DE,	USA)	at	260/280	nm.	Total	RNA	of	each	sample	was	






was	 performed	 using	 qPCR	Mastermix	 Plus	 for	 SYBR	Green	 (Eurogentec,	 the	Netherlands)	





































represents	one	donor	per	 cell	 source	performed	 in	 sextuple.	 For	 statistical	evaluation,	 the	
Kruskal-Wallis	 followed	by	 the	Mann-Whitney-U	tests	was	used	 followed	by	a	Bonferroni's	











weeks,	 DNA	 content	 did	 significantly	 decrease	 in	 constructs	 containing	 hBMSCs	 only	
(p<0.001),	 but	 remained	 unchanged	 in	 the	 remaining	 culture	 conditions.	 (Supplementary	
figure	1)	
Since	 constructs	 were	 cultured	 in	 the	 absence	 of	 chondrogenic	 factors,	 constructs	
containing	 solely	 hAMSCs	 or	 hBMSCs	 produced	 very	 little	 sGAG	 (Figure	 2B)	 and	 collagen	
(Figure	2C).	To	demonstrate	the	additional	effect	of	hMSCs	in	mixed-cell-type	populations,	a	
control	 condition	 -	 containing	 similar	 numbers	 of	 bACs	 (0.8*106	 nc/mL)	 without	 the	




in	 co-cultures	 combining	hBMSCs	 and	bACs	 (p<0.001).	 Constructs	 containing	hAMSC/bACs	
deposited	 significantly	 less	 sGAG	 compared	 to	hBMSC/bACs	 (p<0.001)	 and	 equal	 amounts	




between	 co-cultures	 and	 single-cell-type	 populations:	 hBMSC/bACs	 produced	 significantly	
more	sGAG	compared	to	bACs	only	and	co-cultures	of	hAMSC/bACs	(both	p<0.001)	;	collagen	
production	 was	 significantly	 enhanced	 in	 both	 co-cultures	 (hAMSC/bACs	 p=0.013	 ;	
hBMSC/bACs	p<0.001).	 (Figure	 2B	 and	 2C)	 Similar	 results	were	 obtained	 after	 5	weeks	 of	




























both	 color	 and	 texture,	 while	 the	 appearance	 of	 constructs	 containing	 hAMSC/bACs	 was	
  
particularly	donor-dependent.	(Figure	3)	None	of	the	constructs	had	mineralized	or	ossified.	
Also,	 vascularization	 within	 the	 construct,	 was	 never	 observed.	 Cells	 were	 more	
heterogeneously	 distributed	 in	 constructs	 containing	 either	 hAMSC/bACs	 or	 hBMSC/bACs	
compared	to	bACs	only.	Collagen	type	II	was	abundantly	present	in	constructs	containing	bAC	
















shown)	 hAMSC/bACs	 and	 hBMSC/bACs	 contained	 similar	 quantities	 of	 cartilage	matrix	 as	
constructs	containing	bACs	only.	Moreover	sGAG	formation	in	co-cultures	was	independent	
of	 the	 origin	 of	 the	 hMSC-source	 used	 (p=0.916).	 (Figure	 4A)	 Collagen	 production	
demonstrated	 a	 similar	 trend,	 again	 without	 statistical	 significant	 differences	 between	
hAMSC/bACs	 and	 hBMSC/bACs	 (p=1.000).	 (Figure	 4B)	 Normalization	 of	 the	 data	 to	 their	
initially	seeded	primary	ACs	revealed	more	distinct	differences	between	mixed-cell-type	and	
single-cell-type	 populations:	 hAMSC/bACs	 and	 hBMSC/bACs	 produced	 significantly	 more	
sGAG	and	collagen	per	initially	seeded	primary	ACs	compared	to	bACs	(hAMSC/bACs	p<0.01	;	
hBMSC/bACs	p<0.05).	 (Figure	4)	After	subcutaneous	 implantation,	 the	elastic	modulus	was	
  















containing	 similar	 amounts	 of	bACs	 (0.8*106	 nc	 /ml)	without	 supplementation	 of	hMSCs	 -	was	 evaluated	 to	
determine	 the	additional	effect	of	hMSCs	 (3.2*106	nc	 /ml)	on	bACs	 in	 co-cultures	 (dotted	 line).	 *,	 **	or	***	
indicates	p-values	 smaller	 than	0.05,	0.01	or	0.001	 respectively	 compared	 to	 the	 control	 condition.	Data	are	
shown	as	box-whisker	plots.	For	statistical	evaluation,	a	Kruskal-Wallis	followed	by	the	Mann-Whitney-U	test	was	










hBMSC/bACs	 contained	 cells	 from	 both	 bovine	 (AC)	 and	 human	 (AMSC	 or	 BMSC)	 origin.	
(Figure	 5A)	 Then,	 chondrogenic	 gene	 expression	was	 evaluated	 by	 the	ACAN	 and	 COL2A1	
genes.	In	a	growth-factor-free	environment,	hAMSCs	and	hBMSCs	hardly	expressed	hsACAN	
and	 hsCOL2A1.	 Besides,	 chondrogenic	 genes	 were	 hardly	 expressed	 in	 hAMSC/bACs	 or	
hBMSC/bACs	either.	Conversely,	hAMSC/bACs	or	hBMSC/bACs	-	containing	solely	20%	bovine	










as	 in	 medium	 conditioned	 by	 the	 other	 cell	 type.	 (Figure	 6A	 and	 7A)	 In	 addition	 cell	
combination	were	also	cultured	in	pellets,	allowing	direct	cell-cell	contact.		




of	 factors	 secreted	by	hMSC	significantly	 increased	 the	 total	 amount	of	DNA	 in	 constructs	
containing	 bACs	 (p<0.01).	 This	 effect	 was	 independent	 on	 the	 origin	 of	 the	 hMSCs	 (i.e.	
hAMSCs,	 hBMSCs)	 and	 co-culture	 system	 used	 (i.e.	 Transwell®	 system,	 hMSC-conditioned	
medium).	(Figure	7B)	This	suggests	MSC	have	paracrine	effects	on	chondrocytes.	
Alginate	 constructs	 containing	hAMSCs	or	hBMSCs,	 formed	 very	 little	 sGAG	after	 3	
weeks	 of	 culture.	 sGAG-production	 remained	 similarly	 low	 when	 hMSC-constructs	 were	
cultured	in	the	presence	of	paracrine	factors	of	bAC	via	Transwell®	system	or	bAC-conditioned	




pronounced	 differences.	 sGAG	 formation	was	 significantly	 increased	 in	 Transwell®	 system	
compared	to	constructs	cultured	with	bAC-conditioned	medium	(p<0.01).	(Figure	7B)	Similar	







Data	are	 shown	as	mean	CT-values	±	SD	of	housekeeping	genes	 (A)	 and	average	 relative	gene-expression	of	
chondrogenic	genes	(B).	nd	=	not	detected	(ct-value	>	35.00)	;	hsGAPDH	=	human-specific	GAPDH	;	bsGAPDH	=	
bovine-specific	GAPDH	;	hsACAN	=	human-specific	ACAN	;	bsACAN	=	bovine-specific	ACAN	;	hsCOL2A1	=	human-
specific	 COL2A1	 ;	hAMSC	 =	 human	 Adipose-tissue-derived	Mesenchymal	 Stem	 Cell	 (n=3	 experiments	with	 3	
independent	donors)	;	hBMSC	=	human	Bone-marrow-derived	Mesenchymal	Stem	Cell	(n=3	experiments	with	3	
independent	 donors)	 ;	 bAC	 =	 bovine	 Articular	 Chondrocyte	 (n=3	 experiments	 with	 3	 pools	 of	 donors).	 Per	
experiment,	3	samples	were	used	for	analyses.		
	
Based	 on	 previous	 results,	 we	 further	 wanted	 to	 evaluate	 signs	 of	 hypertrophy	 in	 these	
constructs,	 since	 hypertrophic	 differentiation	 is	 an	 unwanted	 phenomenon	 in	 cartilage	
regeneration.	bACs	cultured	in	‘basic	medium’	expressed	hardly	any	COL10	after	3	weeks	of	
culture.	 In	 addition,	 when	 bACs	 were	 exposed	 to	 paracrine	 factors	 of	 hMSC	 either	 via	
Transwell®	 system	or	hMSC-conditioned	medium,	COL10-gene-expression	was	upregulated	
and	significantly	increased	in	constructs	exposed	to	paracrine	factors	of	hAMSCs	(Transwell®	



















prior	 to	 cell	 culture.	 Data	 are	 shown	 as	 box-whisker	 plots	 of	 6	 samples	 of	 one	 experiment.	 For	 statistical	
evaluation,	a	Kruskal-Wallis	followed	by	the	Mann-Whitney-U	test	was	use	followed	by	a	Bonferroni's	post-hoc	











weeks	 after	 culture	 in	 alginate.	 *,	 **	or	 ***	 indicates	p-values	 smaller	 than	0.05,	 0.01	or	 0.001	 respectively	
compared	 to	 the	 amount	 of	 DNA	 prior	 to	 cell	 culture.	 #	 indicates	 significant	 differences	 from	 all	 conditions	








reduces	 the	 required	 number	 of	 chondrocytes	 and	 diminishes	 many	 disadvantages	 of	
individually	 used	 cell	 types	 leading	 to	 enhanced	 cartilage	 matrix	 formation	 with	 low	
hypertrophic	 differentiation.	 In	 line	 with	 former	 research,	 hAMSC/bACs	 and	 hBMSC/bACs	
produced	similar	or	even	improved	quantities	of	cartilage	matrix	components	as	constructs	
containing	 bACs	 only,	 both	 in	 vitro	 and	 in	 vivo.	 Moreover,	 hypertrophic	 gene	 expression	
(COL10)	was	not	affected	by	hBMSCs,	but	slightly	enhanced	by	hAMSCs.	However,	constructs	
containing	either	hAMSC/bACs	or	hBMSC/bACs	appeared	stable	and	did	not	calcify	 in	vivo.	
This	 suggests	 that	 80%	 of	 bACs	 can	 be	 replaced	 by	 either	 hAMSCs	 or	 hBMSCs	 without	
influencing	cartilage	matrix	production	nor	stability.	Therefore,	mixed-cell-cultures	of	MSCs	



















either	hAMSC/bACs	and	hBMSC/bACs	 in	 vitro	and	 in	 vivo.	 In	 vitro,	hBMSC/bACs	 contained	
significantly	more	cartilage	matrix	components	than	hAMSC/bACs.	Cartilage	formation	after	8	












et	 al.	 demonstrated	 enhanced	 chondrocyte	 proliferation	 capacity	 and	 improved	 sGAG	
formation	 in	 pellets	 containing	 hBMSC/bACs	 compared	 to	 hAMSC/bACs.	 [80]	 Besides,	 3	
independent	 co-culture	 studies	 using	 AMSCs	 only	 showed	 limited	 or	 decreased	 effects	 of	
MSCs	on	chondrogenesis.	[243-245]	Such	effect	was	hardly	seen	in	co-culture	studies	using	
BMSCs	only,	which	may	propose	that,	compared	to	BMSCs,	AMSCs	seem	less	efficient	in	co-
culture,	 Although	 we	 could	 not	 find	 a	 general	 beneficial	 effect	 of	 hBMSCs	 in	 co-cultures	
compared	 to	 hAMSCs	 in	 vitro	 and	 in	 vivo,	 we	 did	 show	 that	 in	 vitro,	 hBMSC/bACs	
outperformed	hAMSC/bACs	 and	 hypertrophic	 gene	 expression	was	 lower	 in	hBMSC/bACs.	
True	 dissimilarities	 between	hAMSCs	 and	hBMSCs	 in	 co-culture	 are	 unfortunately	 hard	 to	










less	 important	 in	our	 study,	 since	alginate	hydrogel	 impedes	direct	 cell-cell	 contact	and	 in	
pellet	culture	no	beneficial	effect	of	direct	cell-cell	contact	was	observed.	On	the	contrary,	





an	optimal	 cell	density	and	 ratio	of	MSCs	 to	ACs	 is	 imperative.	Additionally,	 for	 cell-based	
cartilage	repair,	it	would	be	ideal	to	only	use	low	numbers	of	primary	chondrocytes.	Although	







The	species	mismatch	 limited	 the	 translation	of	presented	basic	 research	 to	clinical	
application.	However,	the	species	mismatch	was	chosen	to	be	able	to	discriminate	between	
the	 role	of	 the	different	 cell	 types.	We	do	not	expect	huge	differences	 in	 fully	human	co-
culture	 models,	 as	 both	 xenogeneic	 and	 autologous	 co-culture	 models	 have	 resulted	 in	
comparable	 outcomes,	 indicating	 that	 in	 both	 models	 comparable	 mechanisms	 are	 likely	
operational.	[74]	Our	results	confirmed	previously	published	results	of	hMSCs	combined	with	
  
xenogeneic	 chondrocytes.	 [74,	273-275]	Therefore,	 it	 appears	 to	be	an	excellent	model	 to	
study	cell-specific	contributions	to	tissue	formation.		
In	conclusion,	this	study	demonstrates	that	80%	of	chondrocytes	can	be	replaced	by	
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Cartilage	 regeneration	 in	 the	 head	 and	 neck	 area:	











However,	 to	 generate	 a	 construct	 of	 reasonable	 size,	 large	 numbers	 of	 chondrocytes	 are	
required,	 which	 limits	 its	 current	 applicability.	 Therefore,	 we	 evaluate	 the	 suitability	 of	 a	
combination	 of	 cells	 for	 cartilage	 regeneration:	 bone-marrow-derived	 mesenchymal	 stem	
cells	and	ear	or	nasal	chondrocytes.	
Human	bone-marrow-derived	mesenchymal	stem	cells	were	encapsulated	in	alginate	
hydrogel	 as	 single-cell-type	 populations	 or	 in	 combination	 with	 bovine	 ear	 or	 nasal	
chondrocytes	at	a	80:20	ratio.	Constructs	were	either	cultured	in	vitro	or	directly	implanted	




stem	 cells	 with	 bovine	 ear	 or	 nasal	 chondrocytes	 contained	 similar	 amounts	 of	 cartilage	
components	 to	 that	 of	 constructs	 containing	 chondrocytes	 only	 (i.e.	 bovine	 ear	 and	 nasal	
chondrocytes).	 In	 vitro,	 species-specific	 gene-expression	 analyses	 demonstrated	 that	
chondrogenic	gene	ACAN	was	expressed	by	the	chondrocytes	only,	which	suggests	a	more	
trophic	 role	 for	 human	 bone-marrow-derived	 mesenchymal	 stem	 cells.	 Furthermore,	 the	










Cartilage	 defects	 in	 the	 head	 and	 neck	 area	 are	 a	 commonly	 encountered	 problem	 in	
reconstructive	surgery.	Currently,	these	defects	are	reconstructed	with	autologous	cartilage	
grafts	or	artificial	implants.	Although	autologous	cartilage	grafting	has	been	used	successfully,	




Cartilage	 tissue	 engineering	 (TE)	 can	 offer	 a	 promising	 solution	 for	 restoring	 missing	 or	
destructed	cartilage	and	has	the	potential	to	overcome	limitations	of	current	treatments,	re-
establishing	unique	biological	and	functional	properties	of	the	tissue.		
To	generate	a	construct	of	 reasonable	 size,	 large	numbers	of	 cells	are	 required.	Currently,	
cartilage	TE	 is	predominantly	based	on	 the	use	of	 two	distinct	 cell	 types:	 chondrocytes	or	
mesenchymal	 stem	 cells	 (MSCs).	 Each	 cell	 type	 is	 however	 associated	 with	 specific	
disadvantages.	Chondrocytes	of	several	anatomical	location	have	been	investigated	for	their	
applicability.	 [39,	40,	42,	44,	46-53,	55-60]	Yet,	 to	obtain	sufficient	numbers	of	autologous	
cells,	 culture-expansion	 seems	 an	 inevitable	 step	 in	 chondrocyte-based	 cartilage	 repair,	
resulting	 in	 generally	 more	 fibrous	 and	 mechanically	 inferior	 cartilage.	 [61]	 MSCs	 on	 the	
contrary,	are	easily	available	from	several	tissues,	can	undergo	multiple	population	doublings	











of	 freshly	 isolated	 primary	 chondrocytes	 leading	 to	 improved	 cartilage	 formation.	 [76]	




cell	 cultures	 of	 MSCs	 and	 non-articular	 chondrocytes,	 such	 as	 ear	 (ECs)	 [77-79]	 or	 nasal	
chondrocytes	(NCs)	[80].	Nonetheless,	the	translation	of	such	basic	research	into	a	one-step	
clinical	 application	 is	 yet	 unfeasible.	 Primarily	 as	 these	 studies	 made	 use	 of	 non-optimal	


















To	 obtain	 primary	 bovine	 chondrocytes	 from	 ear	 (bECs)	 and	 the	 cartilaginous	 part	 of	 the	
nasoseptal	 (bNCs)	 origin,	 macroscopically	 intact	 cartilage	 was	 harvested	 from	 calves	 ≤	 6	
months	old,	and	washed	with	saline	after	careful	resection	of	the	perichondrium	(n=3	pools	
of	 3	 donors).	 To	 isolate	 cells,	 cartilage	 pieces	 were	 incubated	 for	 1	 hour	 with	 2	 mg/mL	
protease,	followed	by	overnight	incubation	with	1.5	mg/mL	collagenase	B	(Roch	Diagnostics,	



















	 Source	 Cell	 density	(x106)	 Source	
Cell	 density	
(x106)	
hBMSC	 hBMSCs	 4	nc/mL	 x	 x	
bEC	 x	 x	 bECs	 4	nc/mL	
bNC	 x	 x	 bNCs	 4	nc/mL	
hBMSC/bEC	 hBMSCs	 3.2	nc/mL	 bECs	 0.8	nc/mL	
hBMSC/bNC	 hBMSCs	 3.2	nc/mL	 bNCs	 0.8	nc/mL	
Control	bEC	 x	 x	 bECs	 0.8	nc/mL	










of	 DMEM	 supplemented	 with	 sodium	 pyruvate	 (Gibco),	 L-proline,	 supplemented	 Insulin	














contents,	 as	 described	 previously.	 [40]	 In	 short,	 the	 amount	 of	 DNA	 was	 determined	 by	
Ethidium	bromide	(GibcoBR1),	using	calf	thymus	DNA	as	a	standard.	Sulfated	GAGs	(sGAGs)	







After	 eight	 weeks	 of	 subcutaneous	 implantation,	 constructs	 were	 harvested,	 set	 in	 2%	
agarose,	fixed	in	4%	formalin	in	PBS	and	embedded	in	paraffin.	Paraffin-embedded	sections	
(6	μm)	were	deparaffinised	and	rehydrated.		
To	 allow	 the	 use	 of	 monoclonal	 mouse	 antibody	 collagen	 type	 II	 (II-II6B3	 1:100;	
Developmental	Studies	Hybridoma	Bank,	USA)	on	constructs	which	had	been	 implanted	 in	













For	mechanical	 characterization,	 constructs	 of	 2.0	mm	 thick	 and	 5	mm	 in	 diameter	 were	





Matlab®	 script	was	 used	 to	 locate	 the	 sample	 surface	 and	measure	 the	 sample	 thickness.	





to	 cartilage	matrix	 formation,	 species-specific	 gene-expression	 analyses	was	 achieved.	 For	
total	RNA	isolation,	alginate	was	dissolved	in	ice-cold	55	mM	sodium	citrate	and	20	mM	EDTA	
in	150	mM	NaCl	and	centrifuged.	Each	cell-pellet	was	subsequently	suspended	in	1	mL	RNA-







was	 performed	 using	 TaqMan®	 Universal	 PCR	 Mastermix	 (Applied	 Biosystems)	 or	 qPCR	







deviation	were	 presented.	 In-vitro	data	 represents	 at	 least	 three	 independent	 donors	 per	
condition	 performed	 in	 triplicate.	 For	 statistical	 evaluation	 of	 these	experiments,	 a	mixed	
linear	 model	 was	 used	 followed	 by	 Fisher's	 least	 significant	 post-hoc	 comparisons	 tests.	
‘Condition’	and	‘time	point’	were	defined	as	fixed	factors	in	the	model.	‘Donor’	and	‘sample	
number’	 were	 treated	 as	 random	 factors.	 For	 the	 in-vivo	 experiments	 six	 constructs	 per	
condition	were	 used,	with	 duplicate	 samples	 for	 three	 independent	 donors.	 For	 statistical	
evaluation	 of	 these	 experiments,	 one-way	 ANOVA	 was	 used	 followed	 by	 Fisher's	 least	
















































the	 additional	 effect	 of	 hBMSCs	 in	 mixed-cell-type	 populations,	 a	 control	 condition	 -	
containing	similar	numbers	of	chondrocytes	without	the	supplementation	of	hBMSCs	-	was	
evaluated	 (Figure	 2	 white	 lines).	 The	 additional	 effect	 of	 hBMSCs	 in	 mixed-cell-type	
populations	was	dependent	on	the	chondrocyte-source	used:	the	addition	of	hBMSCs	to	bNCs	
demonstrated	 a	 significant	 increase	 in	 the	 production	 of	 sGAG	 (p=0.012)	 and	 collagen	
(p=0.007)	compared	to	their	controls	;	no	additional	effects	were	observed	in	hBMSCs/bECs.	
hBMSC/bNCs	contained	significantly	more	sGAG	(p=0.026)	and	collagen	(p=0.040)	compared	
to	 hBMSC/bECs.	 Normalization	 of	 the	 data	 to	 their	 initial	 number	 of	 seeded	 primary	
chondrocytes	 (PCs)	 revealed	more	distinct	differences	between	mixed-cell-type	and	single-
cell-type	populations:	hBMSCs/bECs	 and	hBMSC/bNCs	produced	more	 cartilage	matrix	per	
initial	 seeded	 chondrocyte	 than	 chondrocytes	 only.	 (Figure	 2,	 right)	 Similar	 results	 were	
  
obtained	after	5	weeks.	(Data	not	shown)	These	results	demonstrate	that	hBMSCs	have	an	












(0.8	million/ml)	 without	 supplementation	 of	 hBMSCs	 -	 was	 evaluated	 to	 determine	 the	 additional	 effect	 of	
hBMSCs	(3.2	million/ml)	on	chondrocytes	in	co-cultures	(white	line).	*,	**	or	***	indicates	p-values	smaller	than	
0.05,	0.01	or	0.001	respectively	compared	to	the	control	condition.	Data	are	shown	as	mean	±	SD.	For	statistical	









cell	 type	 (i.e.	hBMSCs,	bECs	 or	bNCs)	 to	 cartilage	matrix	 production	 using	 species-specific	
gene-expression	analyses.	 First,	GAPDH-gene	expression	was	analysed	after	5	weeks	of	 in-
vitro	culture.	hBMSC/bECs	and	hBMSC/bNCs	contained	cells	from	both	bovine	(EC	or	NC)	and	
human	 (BMSC)	 origin.	 (Table	 3)	 Then,	 chondrogenic	 gene	 expression	was	 analysed	 by	 the	
ACAN-gene.	In	a	growth-factor-free	environment,	hBMSCs	hardly	expressed	hsACAN.	Besides,	
hsACAN	 was	 hardly	 expressed	 in	 hBMSC/bECs	 or	 hBMSC/bNCs	 either.	 Conversely,	

















=	 human-specific	 GAPDH	 ;	 bsGAPDH	 =	 bovine-specifiec	 GAPDH	 ;	 hBMSC	 =	 human	 Bone-marrow-derived	











bEC	or	bNCs	 (both	 single-cell-type	and	mixed-cell-type	populations),	but	was	not	visible	 in	
constructs	containing	hBMSCs	only.	(Figure	3).		
In	vivo,	hBMSC/bECs	and	hBMSC/bNCs	contained	similar	quantities	of	cartilage	matrix	
as	 constructs	 containing	 chondrocytes	only.	Moreover	 hBMSC/bNCs	produced	 significantly	
more	 sGAG	 (p=0.004)	 compared	 to	 hBMSC/bECs.	 (Figure	 4A)	 Collagen	 production	
demonstrated	 a	 similar	 trend,	 albeit	 without	 statistical	 significant	 differences.	 (Figure	 4B)	












Macroscopic	appearance	 (top	row)	of	cartilage	constructs,	as	well	as	a	collagen	type	 II	 immunohistochemical	
staining	 (bottom	 row),	 8	 weeks	 after	 subcutaneous	 implantation.	 hBMSC	 =	 human	 Bone-marrow-derived	

















































hBMSC	 /bNCs	 produced	 similar	 quantities	 of	 cartilage	 matrix	 components	 as	 constructs	
containing	chondrocytes	only.	Moreover,	the	cartilage	tissue	formed	seemed	stable	and	did	
not	calcify	 in	vivo.	This	suggests	that	80%	of	the	chondrocytes	can	be	replaced	by	hBMSCs	




By	using	primary	 cells,	we	aimed	 to	 translate	 the	procedure	 towards	a	 single-stage	
clinical	 application.	 Currently,	 for	 articular	 cartilage	 repair,	 two	 clinical	 trials	 are	 already	
designed	as	single-stage	procedures.	[277,	278]	Unfortunately,	the	little	research	performed	
on	mixed-cell	cultures	using	BMSCs	and	ECs	[77-79]	or	NCs	[80],	impeded	the	translation	of	
such	 basic	 research	 to	 a	 clinical	 application,	 since	 these	 studies	made	 use	 of	 non-optimal	
culture	conditions.	First,	 instead	of	using	primary	chondrocytes,	most	research	[77,	78,	80]	
was	performed	with	culture-expanded	chondrocytes,	which	requires	a	two-stages	procedure:	
(1)	 a	 surgical	 procedure	 to	 harvest	 cartilage	 tissue	 for	 chondrocyte	 isolation	 and	 further	
culture-expansion	;	(2)	a	surgical	procedure	to	implant	the	cell-based	cartilage	graft.	Second,	
others	 have	 cultured	 their	 constructs	 in	 growth-factor-enriched	 medium.	 [77,	 80]	 Since	
growth	factors	stimulate	the	re-differentiation	and	differentiation	of	both	culture-expanded	
chondrocytes	 and	BMSCs,	 the	 use	 of	 growth	 factors	might	 have	 interfered	 the	 underlying	
mechanisms	of	cell-cell	interaction	in	their	culture	system.	Moreover,	clinical	use	of	growth	
factors	is	limited	by	the	problem	of	adequate	delivery	[279]	and	the	requirement	of	special	






We	 made	 use	 of	 a	 xenogeneic	 culture	 system	 (i.e.	 bovine	 chondrocytes,	 human	
BMSCs).	 The	 species	 mismatch	 did	 not	 impede	 cartilage	 formation	 confirming	 previously	
published	 results	 of	 hBMSCs	 combined	 with	 xenogeneic	 chondrocytes.	 [74,	 273-275]	








paracrine	 soluble	 factors	 released	 by	 chondrocytes	 enhanced	 the	 chondrogenic	
differentiation	 of	 hBMSCs,	 as	 stated	 by	 others.	 [255-259]	 Although	 the	 importance	 of	
juxtacrine	 or	 gap-junctional	 signalling	 is	 still	 unclear	 in	 literature	 [263],	 our	 mixed	 cells	
encapsulated	 in	 alginate	 hydrogels	 implicated	 that	 such	 signaling	 pathways	 are	 of	 less	
importance	than	paracrine	signaling	pathways,	since	the	alginate	hydrogel	hinders	direct	cell-
cell	contact.		
Besides	 the	 trophic	 effect	 of	 hBMSCs	 on	 chondrocytes	 we	 demonstrated	 that	 this	
effect	 was	 also	 depended	 on	 the	 chondrocyte	 source	 used.	 The	 differences	 between	 the	




equilibrium	 modulus	 than	 bECs.	 Clear	 subtype-specific	 differences	 in	 cartilage	 forming	
potential	is	in	accordance	with	our	previously	published	work,	confirming	that	ECs	and	NCs	





[281]	 Although	 the	 biomechanical	 properties	 of	 the	 constructs	 were	 rather	 low,	 alginate	
enabled	 a	 homogeneous	 cell	 distribution	 and	 prevented	 cells	 from	 floating	 out	 while	





us	 to	 further	 increase	 cell	 density	 due	 to	 limitations	 in	 the	 number	 of	 cells	 available.	
Nevertheless	 it	 allowed	 us	 to	 study	 the	 interactions	 between	 the	 cell	 types.	 For	 clinical	
application,	 it	 would	 be	 ideal	 to	 only	 use	 low	 numbers	 of	 human	 primary	 chondrocytes	
supplemented	with	hBMSCs.	We	have	combined	hBMSCs	and	chondrocytes	at	a	4:1	ratio,	as	
the	 effect	 of	 hBMSCs	 on	 articular	 chondrocytes	 was	 already	 studied	 by	 us	 at	 such	 ratio.	
Although	others	have	used	a	4:1	ratio	for	their	research	as	well	[74,	253],	no	consensus	on	
optimal	 BMSCs-to-chondrocytes	 ratios	 have	 been	 established	 for	 ECs	 and	 NCs.	 Future	
research	 needs	 to	 clarify	 if	we	 could	 further	 reduce	 the	 amount	 of	 primary	 chondrocytes	
without	inhibiting	cartilage	matrix	production.	Finally,	for	future	clinical	application	the	use	of	
allogeneic	 hBMSCs	 can	 be	 considered	 as	 MSCs	 have	 been	 demonstrated	 to	 be	 immune	
  


































(0.8	million/ml)	 without	 supplementation	 of	 hBMSCs	 -	 was	 evaluated	 to	 determine	 the	 additional	 effect	 of	
hBMSCs	(3.2	million/ml)	on	chondrocytes	in	co-cultures	(white	line).	*,	**	or	***	indicates	p-values	smaller	than	
0.05,	0.01	or	0.001	respectively	compared	to	the	control	condition.	Data	are	shown	as	mean	±	SD.	For	statistical	
































cell	 remnants	 from	 elastic	 cartilage.	 Following	 removal	 of	 nuclear	 material,	 the	 obtained	
scaffolds	retained	their	native	collagen	and	elastin	contents	as	well	as	their	architecture	and	
shape.	 High	magnification	 scanning	 electron	microscopy	 showed	 no	 obvious	 difference	 in	
matrix	density	after	decellularization.	However,	glycosaminoglycan	content	was	significantly	
reduced,	 resulting	 in	 a	 loss	 of	 viscoelastic	 properties.	 Additionally,	 in	 contact	 with	 the	
scaffolds,	human	bone-marrow-derived	mesenchymal	stem	cells	remained	viable	and	are	able	
to	 differentiate	 towards	 the	 chondrogenic	 lineage	 when	 cultured	 in	 vitro.	 These	 results,	



















result,	 several	 3D	 scaffolds,	 including	 both	 natural	 and	 synthetic	 materials,	 have	 been	
developed	and	investigated	for	their	use	in	cartilage	reconstruction.	[23,	83,	285]	A	frequently	
used	 alternative	 to	 autologous	 cartilage	 implants	 are	 synthetic	 materials	 such	 as	 porous	
polyethylene	[286,	287].	Although	this	material	 is	advantageous	to	work	with	it	 is	prone	to	
induce	a	foreign	body	reaction,	the	ensuing	extrusion	[124]	in	most	cases	resulting	in	removal	
of	 the	 entire	 implant.	 [288]	 Additionally,	 the	 biomechanical	 mismatch	 of	 the	 implants	
compared	to	normal	ear	cartilage	can	result	in	eventual	collapse	of	the	framework.	[289].	So	







To	date,	 various	 cartilaginous	 structures	have	 already	been	decellularized	 including	
tracheal	 cartilage	 [94-99],	 articular	 cartilage	 [100-103],	 nasal	 cartilage	 [106,	 110],	







Therefore,	 the	 goal	 of	 this	 study	was	 to	 prepare	 decellularized	 ear	 cartilage	 scaffolds	 and	
extensively	characterize	their	biochemical	and	biomechanical	properties,	as	well	as	investigate	










To	 obtain	 full	 thickness	 bovine	 ear	 cartilage	 (bEC),	 macroscopically	 intact	 cartilage	 was	
harvested	from	calves	(n=3)	less	than	8	months	old	(T.	Boer	&	Zn.,	Nieuwerkerk	aan	den	IJssel,	
the	Netherlands)	and	washed	with	phosphate	buffered	saline	(PBS)	after	careful	resection	of	
the	 perichondrium.	 Bovine	 articular	 cartilage	 samples	 (bAC)	 were	 harvested	 from	 the	




at	 Erasmus	 Medical	 Center	 (EMC;	 Rotterdam,	 the	 Netherlands).	 Dermal	 tissue	 was	














the	 protocol	 to	 improve	 the	 removal	 of	 cellular	 remnants.	 Therefore,	 the	 samples	 were	
treated	next	with	a	 low	concentration	elastase	solution	(0.2	M	Tris-HCl	 in	Mili-Q	water,	10	
KIU/mL	aprotinin	and	0.03	U/mL	elastase,	pH	8.6)	for	24	hours	at	37°C,	as	a	high	concentration	













were	 decellularized	 in	 batches.	 Samples	 intended	 for	 histological	 analysis	 and	 SEM	 were	
stored	 in	4%	formaldehyde	and	samples	for	biochemical	analysis	were	stored	dry	at	 -80°C.	
Samples	 intended	 for	 biomechanical	 analysis	 were	 shipped	 to	 Eidgenössische	 Technische	
Hochschule	 (ETH;	 Zurich,	 Switzerland)	 in	 PBS	 containing	 protease	 inhibitors	 (Roche,	 Basel,	
Switzerland)	at	4°C.	Decellularized	bEC	scaffolds	 intended	for	seeding	 (n=1,	 in	6-fold)	were	
pre-conditioned	 for	 at	 least	2	hours	 in	Minimally	 Essential	Medium	Alpha	 (MEM-α;	Gibco,	























12	 M	 HCl	 at	 108°C	 for	 20	 hours,	 dried	 (Savant	 SPD	 121P	 SpeedVac;	 Thermo	 Scientific,	
Massachusetts,	USA)	and	re-dissolved	in	1.5	mL	Mili-Q	water.	Hydroxyproline	contents	were	














agarose,	 dehydrated	 in	 an	 ascending	 series	 of	 alcohol,	 then	 embedded	 in	 paraffin	 and	
sectioned	at	6	µm.	Sections	were	stained	with	Gill’s	Haematoxylin	and	Eosin	(H&E,	Merck),	
Safranin-O	 and	 Resorcin	 Fuchsin	 (RF,	 Klinipath,	 Duiven,	 the	 Netherlands).	 Additionally,	
collagen	type	II	and	elastin	were	immunohistochemically	visualized.	Antigen	retrieval	for	the	




against	 collagen	 type	 II	 (1:100)	or	 elastin	 (1:1000).	An	enzyme-streptavidin	 conjugate	 (HK-
321/325-UK;	Biogenex,	California,	USA)	in	PBS/1%	BSA	at	a	dilution	of	1:100	was	used	as	label	
and	visualized	by	Neu	Fuchsin	substrate	(Chroma,	Köngen,	Germany).	
Cell-seeded	 cartilage	 scaffolds	were	 immediately	 embedded	 in	 Tissue-Tek	OCT	 Compound	









Biomechanical	 properties	 of	 cartilage	 scaffolds	 were	 assessed	 using	 stress-relaxation-
indentation	as	previously	described	[156].	In	short,	samples	(n=3	with	6	samples	per	donor)	
were	 placed	 in	 close-fitting	 stainless	 steel	 cylindrical	 wells	 of	 5	 mm	 in	 diameter,	 while	
immersed	in	PBS	supplemented	with	antibiotic/antimycotic	solution.	Mechanical	testing	was	
performed	with	a	materials	testing	machine	(Zwick	Z005,	Ulm,	Germany)	equipped	with	a	10	











scaffolds	 were	 evaluated	 for	 their	 cytotoxicity	 with	 a	 methylthiazolyldiphenyltetrazolium	
bromide	(MTT)	assay.	Bone-marrow	derived	mesenchymal	stem	cells	(BMSCs)	were	isolated	










washed	 with	 PBS.	 Next,	 5	 mg/mL	 MTT-solution	 was	 added	 and	 incubated	 for	 3	 hours	
protected	from	light	at	37°C	and	5%	CO2.	Finally,	the	scaffolds	were	removed	from	the	wells	
and	 the	MTT-solution	was	 replaced	with	 100%	ethanol	 (Boom,	Meppel,	 the	Netherlands),	
transferred	 to	 a	 96-well	 plate	 and	 absorbance	 was	 measured	 at	 670	 and	 570	 nm	 on	 a	
VersaMax	(Molecular	Devices,	Sunnyvale,	USA).	Toxicity	experiments	were	conducted	twice	
with	 independent	 BMSC	 and	 cartilage	 donors,	 with	 3	 decellularized	 bovine	 samples	 per	
cartilage	type.		






HG;	 Gibco)	 containing	 50	 µg/mL	 gentamicin,	 1.5	 µg/mL	 Fungizone,	 Insulin-Transferrin-
Selenium	(ITS+1,	BD	Biosciences,	New	Jersey,	USA),	40	µg/mL	L-proline,	1mM	sodium	pyruvate	
(Gibco),	25	µg/mL	L-ascorbic	acid	2-phosphate,	10	ng/mL	Transforming	Growth	Factor	beta	1	













To	 assess	 the	 chondrogenic	 differentiation	 of	 the	 BMSCs	 cultured	 on	 the	 scaffolds,	 gene	




was	 isolated	 using	 the	 RNeasy	 Micro	 Kit	 (Qiagen,	 Hilden,	 Germany)	 according	 to	
manufacturer’s	 instructions.	Quantification	of	 total	extracted	RNA	was	determined	using	a	
  
NanoDrop	 ND-1000	 spectrophotometer	 (Thermo	 Fisher	 Scientific	 Inc.,	 Waltham,	 USA)	 at	
260/280	nm.	Next,	complementary	DNA	(cDNA)	was	synthesized	using	the	RevertAidTM	First	
Strand	 cDNA	 Synthesis	 Kit	 (Fermentas	 GmbH,	 Leon-Rot,	 Germany)	 according	 to	
manufacturer’s	 instructions.	 Finally,	 PCR	 analysis	 was	 accomplished	with	 a	 Bio-Rad	 CFX96	
Real-Time	 PCR	 Detection	 System	 using	 TaqMan®	 Universal	 PCR	 Master	 Mix	 (Applied	
Biosystems)	or	qPCRTM	Mastermix	Plus	for	SYBTR®	Green	I	(Eurogentec).	Gene	expression	of	
collagen	 type	 II	 (COL2A1,	 Forward:	 GGCAATAGCAGGTTCACGTACA;	 Reverse:	
CGATAACAGTCTTGCCCCACTT),	 SRY	 (sex	 determining	 region	 Y)-box	 9	 (SOX9,	 Forward:	
CAACGCCGAGCTCAGCA;	 Reverse:	 TCCACGAAGGGCCGC)	 and	 aggrecan	 (ACAN,	 Forward:	
TCGAGGACAGCGAGGCC,	 Reverse:	 TCGAGGGTGTAGCGTGTAGAGA)	 was	 evaluated.	
Glyceraldehyde-3-phosphate	dehydrogenase	(GAPDH,	Forward:	ATGGGGAAGGTGAAGGTCG;	
Reverse:	 TAAAAGCAGCCCTGGTGACC),	 Beta-2-Microglobulin	 (B2M,	 Forward:	
TGCTCGCGCTACTCTCTCTTT;	 Reverse:	 TCTGCTGGATGACGTGAGTAAAC)	 and	 hypoxanthine	
phosphoribosyltransferase	 1	 (HPRT1,	 Forward:	 TATGGACAGGACTGAACGTCTTG;	 Reverse:	
CACACAGAGGGCTACAATGTG),	 were	 used	 to	 determine	 a	 best-housekeeping-gene-index	









Linear	 regression	analysis	was	performed	 to	evaluate	 the	 relationship	between	amount	of	
matrix	 components	 and	 biomechanical	 properties	 after	 decellularization.	 For	 analysis,	 the	
mechanical	properties	(i.e.	σmax,	t1/2	and	Eeq)	were	defined	as	the	dependent	variables	and	
matrix	 components	 (i.e.	 sGAG,	 collagen	 and	 elastin	 content)	 as	 independent	 variables.	
Differences	in	gene	expression	of	the	BMSCs	seeded	on	decellularized	cartilage	scaffolds	were	
determined	 by	Mann-Whitney	 U-tests	 with	 the	 genes	 of	 interest	 (i.e.	 SOX9,	 COL2A1	 and	
ACAN)	 set	 as	 test	 variables.	 Differences	 between	 human	 decellularized	 and	 untreated	
cartilage	samples	for	1	donor	 in	6-fold,	were	determined	by	Mann-Whitney	U-tests	as	well	






















reduced	 (p<0.001)	by	23.5%	 (1.37	±	0.32	mm)	when	compared	 to	untreated	bEC	scaffolds	
(1.72	±	0.40	mm),	while	no	obvious	reduction	in	sample	diameter	was	observed.	(Figure	1A).		
To	 assess	 decellularization	 efficiency,	 cell	 content	was	 analyzed	 histologically	 (H&E	
stain)	and	biochemically.	DNA	content	was	significantly	reduced	(p<0.001)	and	undetectable	
(<10	 ng/sample)	 after	 decellularization,	 compared	 to	 untreated	 bEC.	 Similar	 results	 were	
obtained	in	the	decellularized	bAC	control	scaffolds;	DNA	was	significantly	reduced	(p<0.001)	
and	 undetectable	 after	 decellularization	 compared	 to	 untreated	bAC.	 Histological	 analysis	
showed	that	the	cell	remnants	were	diminished	after	decellularization	and	those	that	were	
still	 present	were	 clearly	 reduced	 in	 size	 and	weakly	 stained	 for	H&E.	 The	 ECM	 itself	was	
weakly	stained	compared	to	the	untreated	scaffolds,	although	the	overall	structure	of	the	ECM	
was	virtually	intact.	(Figure	1B)	








To	 characterize	 the	matrix	 properties	 of	 the	 decellularized	 bEC	 scaffolds,	 the	 sGAG,	 total	
collagen	 and	 elastin	 contents	 were	 measured	 biochemically	 in	 addition	 to	 histological	
evaluation.	 The	 sGAG	 content	 of	 decellularized	 bEC	 scaffolds	 significantly	 reduced	 to	 3%	
(p<0.001)	 compared	 to	untreated	bEC,	which	was	 confirmed	by	histological	 analysis	when	




















(p=0.535).	 Histological	 analysis	 revealed	 that	 after	 decellularization,	 elastin	 was	 mainly	
retained	directly	around	lacunae	when	stained	for	RF.	(Figure	2A)	
The	biomechanical	properties	of	decellularized	cartilage	scaffolds	were	assessed	using	
stress-relaxation-indentation.	 A	 statistically	 significant	 reduction	 of	 all	 compressive	
parameters	was	seen	in	decellularized	bEC	scaffolds	compared	to	the	untreated	bEC	samples	
(p<0.001);	 Equilibrium	modulus	 (Eeq)	 of	 the	 decellularized	 bEC	 scaffolds	 was	 8.7%	 of	 the	
untreated	bEC	scaffolds.	Similarly,	maximum	stress	(σmax)	and	relaxation	half	time	(t1/2)	were	
reduced	 to	 9.2%	 and	 32%	 of	 the	 untreated	 values,	 respectively.	 Specifically,	 σmax	 in	 the	
decellularized	bEC	scaffolds	was	0.54	±	0.36	MPa	and	5.83	±	2.18	MPa	in	untreated	bEC.	t1/2	in	
the	decellularized	bEC	samples	was	0.74	±	0.45	s.	compared	to	untreated	2.31	±	1.5	s.	(Figure	


































(A)	 sGAG,	 collagen	 and	 elastin	 contents	 of	 untreated	 and	 decellularized	 bovine	 ear	 cartilage	 scaffolds.	 Less	
intense	Safranin-O	(Saf-O)	staining	confirmed	sGAG	reduction,	while	immunohistochemistry	of	collagen	type	II	
(Coll-II,	counterstained	with	haematoxylin),elastin	and	resorcin	fuchsin	(RF)	stain	confirmed	retention	of	these	













No	 statistically	 significant	 effect	 on	 the	 metabolic	 activity	 of	 the	 BMSCs	 due	 to	 the	
decellularized	scaffolds	was	found	(p=0.559).	Relative	to	the	control	wells,	90.76	±	8.22%	of	





LIVE/DEAD®	 assay	was	 performed	 after	 21	 days	 of	 culture.	 Living	 BMSCs	 emitted	 a	 bright	
green	fluorescence	and	showed	a	stretched	morphology.	Evaluation	of	z-stacks	indicated	that	
the	seeded	BMSCs	were	present	on	the	surface	of	the	scaffold.	Unseeded,	decellularized	bEC	





the	 expression	 of	 either	 housekeeping	 gene	 was	 non-detectable	 (CT-values	 >40).	 The	












(A)	 H&E	 stain	 of	 decellularized	 ear	 cartilage	 scaffolds	 seeded	 with	 BMSCs	 shows	 attachment	 but	 limited	
migration	(left).	Fluorescent	imaging	(right)	confirms	viability	after	21	days	of	culture.	Images	are	representative	
for	all	samples.	Control	image	consists	of	an	unseeded,	decellularized	bEC	scaffold.	(B)	Relative	expression	of	the	
chondrogenic	markers	 SRY	 (sex	 determining	 region	 Y)-box	 9	 (SOX9),	 Collagen	 type	 II	 (COL2A1)	 and	 aggrecan	
(ACAN)	 are	 similar	 to	 that	 of	 BMSCs	 in	 pellet	 culture	 (positive	 control).	 Dotted	 line	 represents	 the	 relative	
expression	after	culturing	in	monolayer	(negative	control).	Data	shown	as	mean	±	SD	for	1	donor	in	6-fold,	relative	





















(A)	 The	 size	 and	 shape	 of	 a	 whole	 human	 ear	 is	 preserved	 after	 decellularization.	 (B)	 DNA	was	 statistically	
significantly	reduced	after	decellularization	and	a	reduction	in	cell	remnants	is	seen	on	histology	(H&E	stain).	(C)	
sGAG,	 collagen	 and	 elastin	 contents	 of	 untreated	 and	 decellularized	 human	 ear	 cartilage.	 Histological	 stains	
confirm	the	findings.	Data	shown	as	mean	±	SD	for	1	donor	in	6-fold.	(D)	High	magnification	scanning	electron	




For	 successful	 cartilage	 regeneration	 3D-scaffolds	 are	 crucial.	 We	 were	 able	 to	 obtain	
decellularized	bovine	and	human	scaffolds	from	whole	full-thickness	ear	cartilage	(EC)	tissue.	
These	scaffolds	preserved	their	native	collagen	and	elastin	contents,	as	well	as	their	major	




These	 studies,	 however,	 mainly	 focus	 on	 hyaline	 (i.e.	 articular	 cartilage,	 nasal	 cartilage,	
tracheal	 cartilage)	or	 fibrous	 (i.e.	meniscal	 cartilage,	 annulus	 fibrosis)	 cartilaginous	 tissues.	
Other	 cartilage	 decellularization	 techniques	 described	 in	 literature	 are	 the	 fabrication	 of	








the	 structural	 composition	 and	 functionality	 of	 the	 remaining	 ECM.	 Therefore,	
decellularization	outcome	was	evaluated	based	on:	(1)	the	removal	of	cellular	material	and	(2)	
matrix	integrity	which	was	characterized	by	its	components,	architecture	and	biomechanical	




do	not	meet	 this	 requirement	at	all	 [100,	105].	Decellularized	cartilage	scaffolds	 still	 show	
distinct	cell	remnants	on	histological	examination	[94-96,	99-101,	104,	105,	296-299]	or	need	
multiple	 decellularization	 cycles	 to	 remove	 nuclear	material,	 [101,	 299]	 leading	 to	 further	
degradation	 of	 the	 ECM.	 To	 specifically	 decellularize	 EC,	 the	 samples	 were	 decellularized	
according	 to	 the	protocol	 of	 Kheir	et	 al.	 [101]	which	was	 further	 optimized	 to	 ensure	 the	
decellularization	 outcome	 was	 satisfactory	 for	 EC	 and	 cell	 remnants	 reduced.	 The	
incorporation	of	an	additional	24	hour	incubation	with	a	low	concentration	of	elastase	(0.03	






Second,	 the	 balance	 between	 the	 removal	 of	 nuclear	 material	 and	 preserving	 the	
matrix	 integrity	 should	 be	 considered	 carefully.	 We	 showed	 that	 the	 decellularized	 EC	
scaffolds	 preserved	 their	 native	 collagen	 and	 elastin	 contents,	 as	 well	 as	 their	 major	
architecture	 and	 shape,	 while	 sGAG	 content	 significantly	 decreased	 during	 the	 process.	
  







fibrils	 is	 not	 as	 highly	 organized	 as	 that	 of	 native	 ear	 cartilage	 [164,	 303],	 while	 high	
magnification	 SEM	 showed	 that	 the	 decellularized	 EC	 retained	 the	 complex	 interaction	
between	 the	 elastic	 fibers	 and	 fine	 collagen	 network.	 Following	 decellularization,	 sGAG	
content	decreased	significantly	which	corresponds	with	previously	reported	findings	by	others	
[100,	 101]	 and	 was	 most	 likely	 caused	 by	 the	 SDS-treatment	 during	 decellularization.	
Consequently	 with	 the	 sGAG	 reduction,	 the	 viscoelastic	 material	 properties	 of	 the	
decellularized	 EC	 scaffolds	 also	 reduced,	 which	 is	 in	 agreement	 with	 findings	 previously	
reported	by	others.	[304]	Depletion	of	sGAGs	might	be	required	to	allow	cells	and	cell	residuals	






Nevertheless,	 the	 decellularized	 bEC	 scaffolds	 presented	 superior	 mechanical	 properties	
compared	to	that	of	other	commonly	used	natural	or	synthetic	biomaterials	for	cartilage	TE.	
For	 instance,	 low	 equilibrium	 moduli	 were	 found	 by	 unconfined	 compression	 in	 various	
hydrogels;	 maximum	 Eeq	 of	 0.03	 MPa	 in	 2%	 alginate	 constructs	 [210],	 0.3	 MPa	 in	 20%	










choice	of	 cell	 sources	would	mainly	depend	on	 the	application	and	 could	be	any	 cell	with	
chondrogenic	 potential	 such	 as	 chondrocytes,	 perichondrium	 cells	 or	 adipose	 derived	
mesenchymal	 stem	cells.	 [40,	54]	Moreover,	 it	would	not	be	unlikely	 that	 seeding	prior	 to	
implanting	a	decellularized	scaffold	is	required,	as	it	is	the	scaffold	that	could	provide	support	






to	 realize	 cartilage	 revitalization,	 as	 it	 has	 been	 shown	 that	 chondrogenic	 progenitor	 cells	
possess	 the	 capacity	 to	 migrate	 through	 degraded	 cartilage	 and	 repair	 ECM.	 [309]	 This	











as	 a	 band	 around	 the	 lacunae	whereas	 in	hEC,	 this	 network	 extends	more	 into	 the	 ECM,	
confirming	what	is	shown	previously	by	Ito	et	al.	[164]	This	difference	in	elastic	fibers	in	adult	










differentiation	 of	 BMSCs.	 Furthermore,	 the	 translation	 of	 the	 decellularization	method	 to	
whole	 human	 ear	 cartilage	 shows	 the	 possibility	 to	 use	 decellularization	 as	 an	 improved	






Erasmus	MC	SkillsLab)	 and	Cornelia	 Schneider	 (LBI/Red	Cross	Blood	Transfusion	 Service	of	
Upper	Austria)	for	providing	human	cartilage.	Thanks	to	Marcel	Vermeij	(dept.	of	Pathology,	

























The	 protocol	 of	 Kheir	 et	 al.	 [101]	was	 optimized	 by	 the	 incorporation	 of	 a	 low	 dose	 elastase	 to	 specifically	
decellularize	full	thickness	ear	cartilage,	since	decellularization	outcome	was	not	satisfactory	as	cell	remnants	
























Supplementary	 figure	 2.	 Matrix	 integrity	 and	 mechanical	 properties	 of	 bovine	 articular	
cartilage	scaffolds.	



















Tissue	 engineering	 provides	 a	 promising	 alternative	 therapy	 to	 the	 complex	 surgical	
reconstruction	of	auricular	cartilage	by	using	ear-shaped	autologous	costal	cartilage.	Bacterial	
nanocellulose	 is	 proposed	 as	 a	 promising	 scaffold	 material	 for	 auricular	 cartilage	
reconstruction,	as	it	exhibits	excellent	biocompatibility	and	secures	tissue	integration.	Thus,	
this	 study	 evaluates	 a	 novel	 bilayer	 bacterial	 nanocellulose	 scaffold	 for	 auricular	 cartilage	







nanocellulose	 scaffolds	 have	 a	 porosity	 of	 75%	 and	 mean	 pore	 size	 of	 50	 ±	 25	 mm.	
Furthermore,	endotoxin	analysis	and	in	vitro	cytotoxicity	testing	revealed	that	the	produced	
bilayer	bacterial	nanocellulose	 scaffolds	were	non-pyrogenic	 (0.15	±	0.09	EU/ml)	and	non-




combination	 of	 freshly	 isolated	 nasoseptal	 chondrocytes	 and	 mononuclear	 cells	 to	 form	













biopolymer	 synthesized	 by	 various	 bacteria	 species,	 particularly	Gluconacetobacter	 xylinus	
[90,	 324].	 Its	 three-dimensional	 (3D)	 and	 interconnected	 network	 is	 composed	 of	 highly	
hydrated	nanofibrils	ranging	from	70	to	140	nm	in	width,	similar	to	collagen	fibrils	found	in	
extracellular	matrix	 (ECM)	 of	 several	 tissues,	with	 high	 tensile	 strength	 [319,	 325].	 BNC	 is	
considered	 a	 hydrogel	 since	 it	 is	 mostly	 composed	 of	 water	 in	 its	 native	 state	 (99%).	 All	
together,	 these	 outstanding	 properties	 make	 BNC	 an	 exceptional	 biomaterial	 for	 many	
biomedical	applications	[326-328],	including	auricular	cartilage	reconstruction	[316,	322,	329].	
Although	 several	 groups	 have	 attempted	 to	 engineer	 auricular	 cartilage	 [124],	 few	
successful	outcomes	have	been	reported	[330-332].	Development	of	artificial	auricular	grafts	
with	 adequate	 mechanical	 properties	 has	 been	 identified	 as	 a	 key	 factor	 for	 successful	
auricular	 cartilage	 TE	 [333].	Most	 studies	 that	 have	 used	 biodegradable	 scaffold	materials	
have	resulted	in	poor	structural	integrity	(i.e.	shape	and	size	stability)	of	the	auricular	scaffold	
after	implantation;	caused	by	the	short-lived	chemical	and	mechanical	stability	[136,	334-337].	
On	 the	 other	 hand,	 recent	 studies	 that	 have	 investigated	 the	 use	 of	 non-degradable	
biomaterials	for	auricular	cartilage	reconstruction	have	reported	a	better	structural	integrity	
of	 the	 implant	 [330,	 332,	 338]	 -	 likely	 caused	 by	 the	 chemical	 stability	 of	 the	 support	
biomaterial,	which	translates	into	long-lasting	mechanical	properties	even	after	implantation.	
As	opposed	to	the	many	biodegradable	scaffolds	previously	evaluated	for	auricular	cartilage	
TE,	 the	 long-term	 structural	 integrity	 of	 BNC	 scaffolds	 should	 not	 be	 compromised	 after	
implantation	since	humans	do	not	produce	enzymes	capable	of	breaking	down	cellulose	[339].	
Besides	 being	 a	 chemically	 stable	 material,	 BNC	 with	 increased	 cellulose	 content	 of	 17%	
(densified	 hydrogel)	 is	 a	 competitive	 scaffold	 material	 for	 repair,	 reconstruction	 or	
regeneration	 of	 auricular	 cartilage	 since	 it	matches	 the	 elastic	mechanical	 properties	 (e.g.	
equilibrium	modulus)	of	human	auricular	cartilage	[329],	can	be	fabricated	in	patient-specific	
auricular	 shapes	 [340]	 and	 exhibits	 excellent	 biocompatibility	 in	 vivo	 -	 causing	 a	 minimal	
foreign	body	response	[316].	
When	 densified,	 BNC	 hydrogel	 is	 a	 mechanically	 and	 biologically	 appropriate	
biomaterial	 for	 use	 in	 auricular	 cartilage	 reconstruction	 [316,	 329].	 However,	 its	 dense	
nanocellulose	 network	 prevents	 cells	 from	 penetrating	 the	 material.	 To	 circumvent	 this	
problem,	several	techniques	have	been	developed	to	support	cell	ingrowth	in	BNC	scaffolds	




of	 chondrocytes.	 For	 example,	 human	 primary	 articular,	 auricular	 and	 nasoseptal	
chondrocytes	 cultured	 in	macroporous	BNC	 scaffolds	 in	 vitro	 have	been	 shown	 to	adhere,	





cartilage	 repair	 [345].	The	use	of	cells	 in	cartilage	 repair	 is	an	attractive	strategy	as	 it	may	
result	 in	 regeneration	 of	 the	 lost	 tissue.	 However,	 the	 clinical	 application	 of	 a	 cell-aided	
treatment	does	 feature	challenges	–	a	 limited	supply	of	autologous	chondrocytes	with	 the	


























BNC	hydrogel	 disks	with	 increased	 cellulose	 content	 (i.e.	 dense	 layer)	were	 produced	 and	
purified	 as	 described	 elsewhere	 [316].	 Briefly,	 a	 suspension	 of	Gluconacetobacter	 xylinus	




the	 cellulose	 content.	 The	 compressed	 BNC	 pellicles	 were	 frozen	 to	 -80°C	 overnight	 and	
lyophilized	(Heto	PowerDry	PL3000,	Thermo	Fisher	Scientific,	MA,	USA)	for	3	days.	Dense	BNC	
disks	(Ø	8	mm	×	1	mm)	were	then	cut	with	a	sterile	biopsy	punch	(Miltex	GmbH,	Germany).	
The	criterion	 for	selecting	 the	thickness	of	 the	dense	BNC	 layer	 is	based	on	morphometric	
analysis	 from	MRI	 scans	 of	 human	 auricular	 cartilage,	 where	 Nimeskern	 et	 al.	 reported	 a	
cartilage	thickness	of	1.15	±	0.10	mm	[350].	
BNC/alginate	composite	scaffolds	(i.e.	porous	layer)	were	fabricated	by	a	freeze-drying	
process.	 First,	 purified	 BNC	 pellicles	 were	 homogenized	 with	 a	 blender,	 until	 a	 pulp	
consistency	was	obtained,	and	then	with	a	dispersing	element	(S25N-18G,	IKA,	Germany)	at	




















porous	 layers	 and	 achieve	 a	 strong	 interfacial	molecular	 bonding	between	 the	 layers.	 The	










tubes	 (TPP,	 Switzerland)	 with	 endotoxin-free	 water	 (HyClone™	 cell	 culture-grade	 water,	
Thermo	Fisher	Scientific)	supplemented	with	20	mM	CaCl2	to	remove	residuals	of	the	ionic	
liquid	EMIMAc	and	endotoxins.	The	scaffolds	were	purified	under	orbital	motion	(320	rpm)	at	






















number	 (Wall.N)	 were	 calculated	 using	 the	 manufacturer's	 morphometry	 software	 (IPL,	




Endotoxin	 extraction	 from	 the	 bilayer	 BNC	 scaffolds	 was	 done	 in	 accordance	 to	 the	
international	 standard	 ISO	 10993-12:2009	 (Sample	 preparation	 and	 reference	 materials).	
























cytotoxicity	 testing,	according	to	the	 international	standard	 ISO	10993-5:2009.	Bilayer	BNC	
scaffolds	 (n=4	 per	 time	 point)	 were	 incubated	 in	 growth	 medium	 (RPMI	 1640	 medium	
supplemented	with	1%	fetal	bovine	serum	(FBS),	and	antibiotics	(100	U/ml	penicillin	and	100	
µg/ml	streptomycin);	Biochrom,	Germany)	for	24	hours	to	extract	potential	cytotoxic	residues.	




and	 incubated	 for	 24	 hours.	 Cell	 culture	 inserts	 (ThinCertTM,	 Greiner	 BioOne,	 Germany)	
incubated	in	growth	medium	served	as	negative	control	(n=8),	while	10%	dimethylsulfoxide	in	





(Infinite	 M200	 Pro,	 Tecan	 AG,	 Switzerland)	 at	 a	 wavelength	 of	 490	 nm	 and	 a	 reference	
wavelength	of	680	nm.	The	average	absorbance	value	of	 the	negative	control	was	used	to	













the	 cartilage	was	 done	 by	 enzymatic	 digestion	 of	 the	 tissue	with	 0.3%	 type	 II	 collagenase	



















During	 the	 in-vitro	 culture,	 constructs	were	harvested	weekly	 for	 qualitative	 evaluation	of	
neocartilage	 synthesized	 by	 the	 chondrocytes.	 The	 constructs	 were	 fixed	 in	 10%	 neutral	
buffered	formalin	solution	supplemented	with	20	mM	CaCl2	at	room	temperature	overnight,	
embedded	in	paraffin	and	sectioned	(5	μm).	For	assessment	of	sulfated	glycosaminoglycans	
(sGAG)	 and	 cell	 distribution	 within	 the	 bilayer	 BNC	 scaffolds,	 longitudinal	 sections	 were	
stained	with	Alcian	blue	and	counterstained	with	Mayer’s	hematoxylin.	Furthermore,	seeded	




staining,	 slides	were	 incubated	 in	0.5	U/ml	 chondroitinase	ABC	 in	PBS	 for	20	min	at	32°C,	
followed	 by	 incubation	 with	 primary	 antibody	 for	 1	 hour	 at	 a	 1/100	 dilution.	 For	 type	 II	
collagen	 staining,	 slides	 were	 incubated	 in	 1%	 hyaluronidase	 in	 PBS	 and	 0.2%	 pronase	
(Calbiochem,	Germany)	in	PBS,	each	for	15	min	at	37°C,	followed	by	incubation	with	primary	
antibody	for	1	hour	at	a	1/4000	dilution.	For	type	I	collagen	staining,	slides	were	incubated	in	









80°C	 until	 analyzed.	 For	 total	 RNA	 isolation,	 frozen	 constructs	 were	 placed	 in	 2	 ml	
microcentrifuge	tubes	in	quadruples	and	100	µl	of	lysis	buffer	(10	µl	β-Mercaptoethanol	per	1	
ml	Buffer	RLT;	Qiagen,	Germany)	was	added	to	each	tube.	The	samples	were	disrupted	and	
homogenized	 for	 2	minutes	 using	 a	 TissueLyser	 LT	 (Qiagen).	 Subsequently,	 500	 µl	 of	 lysis	
buffer	was	 added	 to	 each	 tube	 and	 the	 cell	 lysate	was	 used	 for	 total	 RNA	 isolation	 using	
RNeasy	Mini	Kit	 (Qiagen),	 according	 to	manufacturer´s	protocol.	 Total	RNA	was	quantified	
using	a	multimode	microplate	reader	(Infinite	M200	Pro,	Tecan	AG)	at	260/280	nm.	cDNA	was	
synthesized	 from	 the	 extracted	 RNA	 using	 QuantiTect	 Reverse	 Transcription	 Kit	 (Qiagen),	




dehydrogenase	 (GAPDH)	was	 used	 as	 housekeeping	 gene.	 Real-time	 two-step	RT-PCR	was	
performed	using	the	Real	Time	ready	RNA	Virus	Master	assay	and	LightCycler®	2.0	instrument	




	 UPL	probe#	 Sense	primer	 Antisense	primer	
	 	 	 	
Target	genes	
ACAN	 79	 5ʹ-TGCAGCTGTCACTGTAGAAACTT-3ʹ	 5ʹ-ATAGCAGGGGATGGTGAGG-3’	
COL1A1	 15	 5ʹ-ATGTTCAGCTTTGTGGACCTC-3ʹ	 5ʹ-CTGTACGCAGGTGATTGGTG-3ʹ	
COL2A1	 19	 5ʹ-CCCTGGTCTTGGTGGAAAC-3ʹ	 5ʹ-	TCCTTGCATTACTCCCAACTG-3ʹ	
VCAN	 54	 5ʹ-GCACCTGTGTGCCAGGATA-3ʹ	 5ʹ-CAGGGATTAGAGTGACATTCATCA-3ʹ	
	 	 	 	
Housekeeping	gene	













standard	 culture	 medium	 at	 37°C,	 5%	 CO2,	 until	 further	 use.	 The	 47	 nasoseptal	 cartilage	
biopsies	were	divided	in	three	pools	for	the	chondrocyte	isolations.	Bone	marrow	aspirate	was	
collected	 from	 three	 donors	 (mean	 age	 70	 years,	 2	 males,	 1	 female)	 during	 total	 hip	
replacement	surgery,	after	acquiring	written	patient	consent.	The	isolations	of	NCs	from	the	
cartilage	 and	MNCs	 from	 the	 bone	marrow	were	 performed	 by	 CellCoTec	 (Bilthoven,	 the	
Netherlands).	Patented	clinically	applied	protocols	were	used	to	isolate	the	cells	within	the	























(1	at	 the	 shoulders	and	1	at	 the	hips),	 after	which	4	 separate	 subcutaneous	pockets	were	
prepared	by	blunt	dissection	of	 the	 subcutaneous	 tissue.	 The	overall	 behavior	 and	wound	
healing	at	the	implant	sites	were	assessed	macroscopically	over	the	implantation	period.	Eight	
weeks	 after	 subcutaneous	 implantation,	 animals	 were	 terminated	 and	 samples	 were	
explanted.	Each	sample	was	cut	in	half	and	one	part	was	used	for	histology	and	the	other	part	
for	 biomechanical	 and	 biochemical	 analyses.	 Animal	 experiments	 were	 carried	 out	 with	







To	 examine	 proteoglycans	 present	 in	 the	 newly	 synthesized	 ECM,	 deparaffinized	 sections	
were	 stained	with	 Safranin	O	 and	 fast	 green.	 To	 allow	 the	 use	 of	 the	monoclonal	mouse	
antibody	collagen	type	II	(II-II6B3,	1:100;	DSHB)	on	constructs	which	had	been	implanted	in	
nude	mice,	we	coupled	the	first	and	second	antibody	before	applying	them	on	the	sections	to	
prevent	 unwanted	 binding	 of	 the	 anti-mouse	 antibodies	 to	 mouse	 immunoglobulins,	 as	
described	previously	 [214].	 In	 short,	 the	primary	antibody	was	pre-coupled	overnight	with	
goat	anti-mouse	biotin	at	4°C	(1:500;	Jackson	Laboratories,	ME,	USA),	followed	by	a	2	hour	
incubation	 in	 0.1%	 normal	 mouse	 serum	 (CLB,	 the	 Netherlands)	 in	 order	 to	 capture	 the	
unbound	 second	antibody.	Antigen	 retrieval	was	performed	 through	 incubation	with	0.1%	
pronase	 in	 PBS	 for	 30	 minutes	 at	 37°C,	 followed	 by	 a	 30	 minute	 incubation	 with	 1%	
hyaluronidase	in	PBS	at	37°C.	Non-specific	binding	sites	were	blocked	with	10%	goat	serum	in	
PBS	and	sections	were	stained	with	the	pre-treated	antibodies	for	60	minutes.	Sections	were	
















Mechanical	 properties	 of	 the	 retrieved	 constructs	 (n=8,	 MNC/NC-seeded	 and	 cell-free	
scaffolds)	and	non-implanted	bilayer	BNC	scaffolds	containing	cell-free	alginate	solution	(n=5,	
non-implanted	 group)	were	 assessed	with	 uniaxial	materials	 testing	machine	 (Z005,	 Zwick	
GmbH,	Germany)	 equipped	with	 a	 10	N	 load	 cell,	 a	 cylindrical	 plane-ended	 stainless	 steel	
indenter	(Ø	0.35	mm)	and	a	built-in	displacement	control.	Bilayer	BNC	scaffolds	were	placed	
in	 close-fitting	 stainless	 steel	 cylindrical	 wells	 containing	 PBS	 supplemented	 with	 1%	
antibiotic/antimycotic	 solution.	 Stress	 relaxation	 testing	 was	 performed	 as	 described	
previously	 [354].	 Briefly,	 a	 preload	of	 3	mN	was	 first	 applied	 on	 the	 sample	 to	 locate	 the	
sample	surface	and	measure	sample	thickness,	and	held	for	5	minutes.	Five	successive	strain	
steps	were	then	applied	 in	5%	 increments	of	 the	original	sample	thickness,	and	specimens	
were	left	to	relax	for	20	minutes	at	each	step.	The	hold	time	was	defined	as	the	time	necessary	
to	reach	equilibrium.	Two	locations	were	tested	on	each	sample	(center	of	the	sample,	and	
1.2	mm	off-center).	Measurements	of	maximum	stress	 (σmax),	 instantaneous	modulus	 (Ein)	
and	 equilibrium	 modulus	 (Eeq)	 were	 computed	 from	 the	 stress-strain	 curves,	 which	 are	
normalized	for	sample	thickness.	Additionally,	a	relaxation	half-life	time	(t1/2),	defined	as	the	
  





Statistical	 analyses	 were	 performed	 with	 Statgraphics	 Centurion	 Version	 17	 (Statpoint	
Technologies,	VA,	USA).	For	cytotoxicity	analysis,	comparison	of	means	was	assessed	by	one-
way	ANOVA,	followed	by	Tukey’s	HSD	test	for	post	hoc	comparisons.	For	biochemical	analysis,	



























































	 	 	 	 	 	
1	 1/10	 0.26	 59	 Valid	 0.15	±	0.09	
2	 1/10	 0.10	 90	 Valid	 	
3	 1/10	 0.10	 55	 Valid	 	
	
Table	2.	
Results	 from	 bacterial	 endotoxin	 testing.	 Assay	 sensitivity	 0.005	 Endotoxin	 Units	 per	 ml	 (EU/ml).	 Valid	 test	













from	 the	 bilayer	 BNC	 scaffolds.	 (Figure	 3A)	 In-vitro	 cytotoxicity	 testing	 supported	 this	
observation.	An	one-way	ANOVA	was	conducted	to	compare	the	effect	of	cytotoxic	residues	




condition	 (97.8	 ±	 4.7%)	was	 significantly	 higher	 than	 the	 7-day	 (18.4	 ±	 3.6%)	 and	positive	



















Gross	 examination	 of	 the	 cell-seeded	 constructs	 throughout	 the	 6	 weeks	 of	 cell	 culture	
revealed	that	the	adhesion	between	the	dense	support	layer	and	porous	layer	remained	good.	
Moreover,	 the	 size	and	shape	of	 the	bilayer	BNC	scaffolds	 remained	stable	during	 the	cell	
culture.	 Deposition	 of	 ECM	 by	 the	 NCs	 seeded	 in	 bilayer	 BNC	 scaffolds	 was	 assessed	
qualitatively	 by	 immunohistological	 staining.	 During	 3D	 culture,	 NCs	 produced	 and	
accumulated	 cartilage-specific	 ECM	 components	 in	 the	 bilayer	 BNC	 scaffolds.	 A	 positive	








the	BNC	scaffold	was	also	 investigated	on	 the	basis	of	 the	expression	of	 the	chondrogenic	
marker	genes	ACAN	and	COL2A1.	To	assess	whether	the	NCs	were	able	to	redifferentiate	and	
maintain	their	chondrogenic	phenotype,	the	expression	not	only	of	the	chondrogenic	markers	
but	 also	 of	 the	 dedifferentiation	 markers,	 VCAN	 and	 COL1A1,	 was	 determined.	 Gene	
expression	 analyses	 confirmed	 the	 positive	 immunostains	 of	 aggrecan,	 type	 II	 and	 type	 I	
collagen.	NCs	cultured	in	bilayer	BNC	scaffolds	were	able	to	express	ACAN	and	COL2A1.	The	




during	 3D	 culture,	where	 after	 6	weeks	was	 1.7-fold	 higher	 compared	 to	 gene	 expression	
levels	at	week	2.	On	the	other	hand,	expression	of	VCAN	 remained	relatively	close	to	zero	
during	the	6	weeks	of	3D	culture.	(Figure	4E,	F)	The	upregulation	of	the	chondrogenic	markers	















bilayer	 BNC	 scaffolds	 -	 considered	 a	 normal	 non-pathological	 foreign	 body	 reaction.	
Macroscopic	examination	of	the	explants	revealed	that	the	shape	and	size	of	the	bilayer	BNC	
scaffolds	remained	stable	and	no	delamination	of	the	dense	and	porous	layers	was	observed	
in	 any	 of	 the	 constructs.	 Furthermore,	 bilayer	 BNC	 scaffolds	 seeded	 with	MNCs	 and	 NCs	
encapsulated	 in	 alginate	 had	 a	macroscopically	 cartilage-like	 appearance.	 These	MNC/NC-
seeded	 constructs	 were	 stiffer	 and	more	 stable	 upon	 handling,	 compared	 to	 bilayer	 BNC	
scaffolds	 seeded	 with	 cell-free	 alginate	 solution.	 The	 cells	 encapsulated	 in	 alginate	 were	
homogeneously	distributed	in	the	porous	layer	of	the	scaffolds	at	8	weeks	post-implantation,	
as	observed	by	the	histology	images.	(Figure	5B)	








(0.87	 ±	 0.65	 μg	 sGAG/mg	wet	weight)	 and	 cell-free	 bilayer	 BNC	 scaffolds	 (0.07	 ±	 0.11	 μg	

















































to	 detect	 type	 II	 collagen.	 (C)	 Cell-free	 and	MNC/NC-seeded	 bilayer	 BNC	 scaffolds	 were	 analysed	 for	 sGAG	
content	after	8	weeks	of	subcutaneous	implantation	(n=4	per	group).	A	two-sample	Kolmogorov-Smirnov	test	
indicated	a	significant	difference	between	mean	sGAG	content	 for	MNC/NC-seeded	and	cell-free	bilayer	BNC	
scaffolds.	 (D)	 Biomechanical	 evaluation	 of	 cell-free	 and	 MNC/NC-seeded	 constructs	 after	 8	 weeks	 of	
subcutaneous	 implantation	 (n=4	 per	 group),	 and	 non-implanted	 bilayer	 BNC	 scaffolds	with	 cell-free	 alginate	
solution	 (n=5).	Post	hoc	comparisons	using	 the	Tukey	HSD	 test	 indicated	 that	 the	mean	Ein	 for	 the	MNC/NC	
condition	 was	 significantly	 higher	 than	 the	 non-implanted	 and	 cell-free	 conditions.	 Moreover,	 post	 hoc	














devices	 [352].	 This	 low	 endotoxin	 content	 (0.15	 ±	 0.09	 EU/ml)	 found	 in	 the	 bilayer	 BNC	
scaffolds	is	in	good	agreement	with	our	previous	results	(0.10	EU/ml,	[316]),	where	densified	
BNC	hydrogel	disks	 (i.e.	dense	 layer)	of	 similar	dimensions	were	considered	non-pyrogenic	
after	purification	with	endotoxin-free	water	for	14	days.		
The	 ionic	 liquid	EMIMAc	offers	a	novel	cellulose	solvent	system	to	achieve	a	strong	



















In-vitro	 cytotoxicity	 testing	 supported	 our	 findings	 from	 ATR-FTIR.	 Bilayer	 BNC	
scaffolds	washed	for	7	days	still	had	residues	of	EMIMAc	that	were	highly	cytotoxic	to	L929	




non-cytotoxic	 [316].	 Altogether,	 the	 results	 from	ATR-FTIR	 and	 in	 vitro	 cytotoxicity	 testing	




Macroscopic	examination	of	 the	bilayer	BNC	scaffolds	after	 the	 in	vitro	and	 in	vivo	 studies	
revealed	that	the	adhesion	between	the	dense	and	porous	layers	remained	stable,	as	there	
were	 no	 signs	 of	 adhesive	 failure.	We	 postulate	 that	 the	 interfacial	 bonding	 between	 the	
layers	is	like	a	molecular	welding	process.	As	the	BNC-EMIMAc	solution	partly	dissolves	both	
surfaces	at	the	interface,	this	makes	it	possible	for	the	long	chains	of	BNC	to	diffuse	into	both	











vitro	 [343],	 bilayer	 BNC	 scaffolds	 also	 supported	 the	 redifferentiation	 of	 NCs	 to	 a	 more	
chondrogenic	phenotype,	which	led	to	the	formation	of	neocartilage;	as	demonstrated	by	the	
increase	 in	 gene	 expression	 of	 chondrogenic	 marker	 genes	 ACAN	 and	 COL2A1	 and	
homogeneous	distribution	of	cartilage-specific	ECM	after	6	weeks	of	in	vitro	culture.	Although,	














In	 the	 in-vivo	 study	we	explored	 the	application	of	 a	 clinically	 relevant	 strategy,	by	
seeding	 bilayer	 BNC	 scaffolds	with	 a	 low	 number	 of	 freshly	 isolated	 human	 chondrocytes	
combined	with	freshly	isolated	human	mononuclear	cells,	in	order	to	test	the	translation	of	
this	auricular	cartilage	TE	technology	to	the	clinic.	At	8	weeks	post-implantation,	deposition	
of	 cartilage	matrix	 components	 such	 as	 proteoglycan	 and	 type	 II	 collagen	 were	 observed	
predominantly	 in	MNC/NC-seeded	constructs.	The	 strong	Safranin-O	stain	 surrounding	 the	
cells	showed	the	presence	of	proteoglycans	in	the	newly	synthesized	ECM,	while	the	presence	











the	 three	 conditions.	 Considering	 the	 improved	 relaxation	 kinetics	 in	 the	MNC/NC-seeded	
constructs,	we	conclude	that	the	ability	of	the	MNC/NC-seeded	scaffolds	to	attract	and	trap	
water	 was	 enhanced	 through	 the	 production	 and	 accumulation	 of	 proteoglycans	 and	
glycosaminoglycans	 in	 the	 bilayer	 BNC	 scaffolds.	 Nevertheless,	 since	 the	 intrinsic	 scaffold	
properties	did	not	improve	in	the	MNC/NC-seeded	constructs	compared	to	the	no	cell	control	
(no	 difference	 in	 Eeq),	 it	 implies	 that	 collagen	matrix	was	 not	 effectively	 produced	 in	 the	
porous	layer.	To	put	the	results	from	the	biomechanical	analysis	in	a	clinical	context,	the	values	







engineering	 functional	 and	 stable	 cartilage.	 Others	 have	 demonstrated	 that	 cell	 densities	
greater	 than	20	×	106	cells/ml	are	desirable,	while	 low	cell	densities	 resulted	 in	decreased	
cartilage	formation	[360].	During	embryology	of	cartilage,	densely	packed	and	proliferative	
mesenchymal	 cells	 are	 responsible	 for	 depositing	 the	 vast	 amount	 of	 cartilage	 ECM.	 In	
cartilage	 TE,	 early	 phase	 of	 cartilage	 development	 needs	 to	 be	 simulated	 to	 generate	
functional	 and	 stable	 cartilage.	 Therefore,	 in	 order	 to	 enhance	 the	 outcome	 of	 tissue-
engineered	auricular	cartilage,	a	higher	cell	density	is	needed	to	benefit	from	increased	cell-
cell	 contacts	 signaling	 chondrogenic	 ECM	 deposition	 and	 preventing	 the	 dedifferentiation	
process.	Despite	the	limitations	already	stated,	our	findings	support	that	bilayer	BNC	scaffolds	
in	combination	with	alginate	provide	a	suitable	environment	for	MNCs	and	NCs	to	support	the	





tissue	 formation.	 It	 would	 be	 ideal	 if	 the	 scaffold	 could	 be	 degraded	 by	 the	 time	 the	
neocartilage	has	reached	full	mechanical	strength.	However,	fine-tuning	this	intricate	play	has	







with	 the	host	 tissue	 in	different	animal	models	 [313,	314,	316,	361].	A	novel	BNC	scaffold	
designed	with	a	bilayer	architecture	that	integrates	mechanical	stability	and	high	porosity	was	
successfully	 fabricated	 and	 evaluated	 for	 auricular	 cartilage	 TE,	 in	 vitro	 and	 in	 vivo.	 In	
conclusion,	 this	 study	 demonstrates	 that	 non-pyrogenic	 and	 non-cytotoxic	 bilayer	 BNC	
scaffolds	can	be	successfully	produced.	Furthermore,	such	scaffolds,	together	with	alginate,	
provide	a	 suitable	environment	 for	 culture-expanded	human	nasoseptal	 chondrocytes	and	
freshly	 isolated	 human	 nasoseptal	 chondrocytes	 combined	 with	 freshly	 isolated	 human	
mononuclear	 cells	 to	 form	 cartilage	 in	 vitro	 and	 in	 vivo.	 Most	 studies	 that	 have	 used	
biodegradable	 materials	 to	 engineer	 auricular	 cartilage	 have	 resulted	 in	 poor	 structural	
integrity	 of	 the	 scaffold	 after	 implantation	 due	 to	 the	 short-lived	 chemical	 stability	 of	 the	
scaffold	material.	This	study	found	that	bilayer	BNC	scaffolds	offer	a	good	mechanical	stability	
and	maintain	a	structural	 integrity	while	providing	a	porous	architecture	that	supports	cell	
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limited	 capacity	 for	 self-regeneration.	 Currently,	 these	 defects	 are	 reconstructed	 with	
autologous	cartilage	grafts	or	artificial	 implants.	Although	autologous	cartilage	grafting	has	





missing	 or	 destructed	 cartilage	 and	 has	 the	 potential	 to	 overcome	 limitations	 of	 current	











Q3	 Which	 natural	 scaffolds	 (i.e.	 alginate,	 bacterial	 nanocellulose,	 decellularized	








Replacing	 damaged	 or	 missing	 cartilage	 requires	 an	 accurately	 sculpted	 cartilaginous	
framework	that	provides	sufficient	strength	and	stiffness	to	substitute	for	the	biomechanical	
properties	 of	 the	 damaged	 cartilage	 in	 order	 to	 resist	 tissue	 deformation.	 Moreover,	 a	
cartilage	framework	that	is	too	stiff	may	give	an	unnatural	contour	and	may	cause	shearing	
forces	of	the	overlying	tissue,	resulting	in	graft	failure.	Currently,	costal	cartilage	is	widely	used	
as	 graft	 material	 for	 the	 replacement	 of	 facial	 cartilages.	 However,	 its	 biomechanical	
properties	are	evidently	different	from	that	of	ear	and	nasal	cartilages.	[362]	Ideally,	tissue-
engineered	 cartilage	 should	 overcome	 this	 biomechanical	 mismatch	 and	 possess	 similar	





studies	 were	 relatively	 small	 and	 frequently	 used	 tensile	 behaviour	 to	 reflect	 biomaterial	
properties,	which	requires	large	sample	dimensions	and	complicates	the	translation	towards	
biomechanical	properties	of	tissue-engineered	cartilage	constructs.	Chapters	two	and	three	
present	 the	 equilibrium	 behaviour	 (Eeq)	 of	 stress-relaxation	 indentation	 to	 study	
biomechanical	behaviour	of	native	facial	cartilages	(i.e.	ear,	nasoseptal	and	alar	cartilages)	to	
































that	 ear	 and	 alar	 cartilage	 have	 lower	 moduli	 compared	 to	 septal	 cartilage,	 with	 helical	
cartilage	being	the	softest	region	of	the	ear.	[28,	363]	To	be	able	to	understand	biomechanical	
behaviour	of	facial	cartilages,	one	should	realise	that	cartilage	biomechanics	are	determined	
by	 ECM	 composition	 and	 architecture.	 In	 hyaline	 cartilage	 (i.e.	 nasoseptal	 cartilage),	
biomechanical	 behaviour	 is	mainly	 the	 consequence	 of	 the	 swelling	 of	 negatively	 charged	
aggregated	 proteoglycans	 trapped	 into	 a	 collagen	 fiber	 network.	 [202]	 The	 biomechanical	
properties	of	ear	and	alar	 cartilage	are	also	 influenced	by	 the	presence	of	 an	elastin	 fiber	
  
network	in	the	ECM.	In	fact,	compressive	biomechanical	integrity	appears	mainly	assigned	by	
elastin,	 whereas	 in	 hyaline	 cartilage	 this	 is	 principally	 provided	 by	 a	 complex	 relationship	
between	the	collagen	network	entrapping	glycosaminoglycans.	[202]	Biomechanically,	elastin	
is	responsible	for	the	physical	properties	of	elasticity,	reversible	extensibility	and	elastic	recoil.	
[144]	 Moreover,	 elastin	 is	 localized	 in	 close	 proximity	 to	 proteoglycans,	 altering	 the	
proteoglycan-ECM	binding	paradigm	we	know	from	hyaline	cartilage,	and	thereby	influencing	
biomechanical	 behaviour.	 [202]	 Therefore,	 elastic	 cartilage	 displays	 a	 distinctly	 different	
























specific	 requirements	 on	 the	 cell	 source.	 The	 ideal	 cell	 source	 should	 meet	 specific	







ear,	 and	 nose)	were	 studied.	 Independent	 on	 their	 origin,	 culture-expanded	 chondrocytes	





biological	 or	 biophysical	 stimuli.	 [365]	 However,	 induction	 factors	 can	 enhance	 but	 never	
emulate	the	complex	process	of	cartilage	regeneration	and	may	have	unpredictable	effects	
on	future	clinical	outcome.		
Multipotent	 mesenchymal	 stem	 cells	 (MSCs)	 achieved	 considerable	 attention	 as	
alternative	 cells.	 They	 can	 undergo	 multiple	 population	 doublings	 without	 losing	 their	
chondrogenic	 potential	 and	 have	 the	 capacity	 to	 differentiate	 into	 cartilage	 tissue	 under	
appropriate	culture	conditions.	[64-68]	Furthermore,	MSCs	are	easily	available	from	several	
tissues,	 including	 bone	 marrow	 and	 adipose	 tissue,	 which	 makes	 culture-expansion	
unnecessary.	 However,	 their	 role	 in	 cell-based	 cartilage	 repair	 is	 currently	 debated,	 since	
MSCs	terminally	differentiate	through	the	process	of	endochondral	ossification.	They	produce	
cartilage	 ECM	 that	 is	 unstable	 (chapter	 four)	 and	 predisposed	 to	 mineralization	 and	
ossification	in	vivo.	[69-71,	240,	241]	However,	significant	research	is	required	to	understand	
















that	 only	 chondrocytes	 derived	 from	 elastic	 cartilage	 are	 able	 to	 produce	 an	 elastin-rich	
cartilage	matrix	and	that	chondrocytes	derived	from	hyaline	cartilage	are	not.	Moreover,	the	
properties	 of	 the	 ECM	 of	 location-specific	 hyaline	 chondrocytes	 (i.e.	 nasal	 or	 articular	
chondrocytes)	 are	mutually	 different	 and	 remarkably	 related	 to	 their	 origin.	 Thereby,	 we	
further	 completed	 former	 research	 [56,	 366]	 and	 conclude	 that	 location	 and	 type-specific	
chondrocytes	 ultimately	 result	 in	 cartilage	 regeneration	 of	 similar	 molecular	 nature.	 This	
means	that	for	the	reconstruction	of	cartilage	defects	in	the	head	and	neck	area,	ear	and	nasal	
chondrocytes	 are	 favorably	 used	 to	 repair	 ear	 or	 nasal	 cartilage	 defects	 respectively.	





of	 cartilage	matrix	 components	 as	 constructs	 containing	 chondrocytes	 only.	 Therefore,	 80	
  
percent	 of	 the	 chondrocytes	 can	 easily	 be	 replaced	 by	MSCs	without	 influencing	 cartilage	
matrix	 production.	 Co-culture	 supports	 the	 use	 of	 primary	 chondrocytes	 without	 the	








cell	 type.	 In	 combination	 with	 chondrocytes,	 pluripotent	 stem	 cells	 improve	 cartilage	
formation	in	vitro	and	in	vivo.	[373-376]	However,	the	use	of	human	ESCs	and	iPSCs	is	currently	
impeded	 by	 the	 risk	 of	 teratoma	 formation	 and	 oncogenicity.	 [377,	 378]	 Moreover,	 the	
application	 of	 human	 ESCs	 raise	 ethical	 concerns	 regarding	 their	 isolation	 from	 human	
embryos.	To	date,	pluripotent	stem	cells	seems	mainly	valuable	for	research	purposes	and	not	
yet	for	clinical	application.	
Stem	 cells	 that	 have	 been	 most	 extensively	 studied	 for	 their	 application	 in	
chondrogenic	 co-cultures	 are	 MSCs.	 Unlike	 pluripotent	 stem	 cells,	 MSCs	 are	 multipotent	
possessing	 committed	 lineage	 differentiation	 potential	 and	 lacking	 unlimited	 self-renewal	
capacity.	They	are	however	(1)	easily	available	from	several	tissues,	including	bone	marrow,	
adipose	tissue,	synovium,	peripheral	blood,	dental	pulp,	placenta,	umbilical	cord,	and	skeletal	










only	 involved	 in	 WNT-signaling	 and	 differentiation	 pathways,	 whereas	 genes	 expressed	
uniquely	by	AMSCs	were	 responsible	 for	cellular	communication	and	 transcription	control.	
[232]	 In	addition,	18%	of	 the	generated	proteins	were	 found	 to	be	differentially	produced	












246,	 247]	 Unfortunately,	 these	 studies	 demonstrate	 conflicting	 outcomes	 and	 have	 never	
translated	 to	 animal	 or	 preclinical	 research.	 Acharya	 et	 al.	 demonstrated	 enhanced	
chondrocyte	 proliferation	 capacity	 and	 improved	 sGAG	 formation	 in	 pellets	 containing	
BMSC/chondrocytes	 compared	 to	 AMSC/chondrocytes.	 [80]	 Besides,	 3	 independent	 co-
culture	 studies	 using	 AMSCs	 showed	 limited	 or	 decreased	 effects	 of	 AMSCs	 on	
chondrogenesis.	 [243-245]	 Such	effect	was	hardly	 seen	 in	 co-culture	 studies	using	BMSCs,	
which	 may	 propose	 that,	 compared	 to	 BMSCs,	 AMSCs	 seem	 less	 efficient	 in	 co-culture.	
Although	 we	 could	 not	 find	 a	 general	 beneficial	 effect	 of	 human	 BMSCs	 in	 co-cultures	
compared	to	human	AMSCs	in	chapter	five,	we	did	show	that	 in	vitro,	BMSC/chondrocytes	
outperformed	 AMSC/chondrocytes	 and	 hypertrophic	 gene	 expression	 was	 lower	 in	
BMSC/chondrocytes.	True	dissimilarities	between	human	AMSCs	and	BMSCs	in	co-culture	are	
unfortunately	hard	to	expose,	as	human	MSC-cultures	are	highly	heterogeneous	and	distinct	
population	 subsets	 probably	 interfere	with	 the	 reciprocal	 communication	 pathways	 in	 co-




MSCs	 and	 chondrocytes	 is	 under	 debate	 in	 literature.	 Numerous	 cellular	 communication	
pathways	have	been	hypothesized	in	order	to	explain	the	beneficial	effect	in	co-cultures	[73]:	
(1)	 Chondrocyte-driven	 MSC-differentiation	 or	 (2)	 MSC-driven	 chondro-induction	 are	
considered	 the	 most	 plausible	 of	 them.	 [81]	 In	 recent	 years,	 the	 trophic	 and	 paracrine	
functions	of	MSCs	appeared	most	 critical	 in	 this	process,	 rather	 than	 simple	 chondrogenic	
differentiation	 of	MSCs	 alone	 as	 stated	 previously.	 [80,	 253-262]	 In	 accordance	 to	 former	
research	 [74,	 246,	 263-268],	we	demonstrate	 (chapter	 five	 and	 six)	 that	 both	AMSCs	 and	






beneficial	 effect	 of	 direct	 cell-cell	 contact	 was	 observed.	 On	 the	 contrary,	 MSC-driven	
chondro-induction	was	less	pronounced	in	Transwell®	system	and	this	effect	was	even	further	
reduced	by	MSC-conditioned	medium.	Although	direct	cell-cell	contact	seems	less	significant	

















Currently,	 several	3D	 scaffolds	have	been	developed	and	 investigated	 for	 their	use	 in	 cell-
based	cartilage	repair.	[83]	They	can	be	roughly	classified	into	synthetic	and	natural	scaffolds,	
and	numerous	of	them	have	been	introduced	in	the	field	of	cartilage	tissue	engineering.	[83]	








Scaffold	 selection	 have	 been	 an	 important	 pillar	 of	 the	 tissue	 engineering	 process.	 The	
contemporary	concept	of	scaffold	engineering	is	to	mimic	the	natural	micro-architecture	of	
the	3D	ECM	of	the	targeted	tissue	itself.	Scaffold	design	should	thereby	substitute	for	the	cell	
natural	 environment	providing	 instantaneous	 cell	 support	 and	 guiding	 tissue	development	
and	remodelling.	 Intuitively,	native	ECM	has	the	potential	to	be	the	most	 ideal	scaffold	for	




cellular	 and	 nuclear	 antigens	 [94].	 Moreover,	 ECM-derived	 scaffolds	 provide	 specific	
structural,	mechanical	and	biological	cues	to	cells	guiding	tissue	regeneration	and	remodeling.	
[82]	The	preparation	as	well	as	the	biocompatibility	of	a	decellularized	cartilaginous	ECM	was	
extensively	 studied	 in	 chapter	 seven.	 In	 fact,	we	were	 the	 first	 to	 evaluate	 structural	 and	
functional	properties	of	decellularized	full-thickness	ear	cartilage	scaffolds.	Ear	cartilage	was	
decellularized	utilizing	the	protocol	of	Kheir	et	al.	[101]	and	modified	by	the	incorporation	of	













critical	 for	 future	 clinical	 implementation.	 Recellularized	 ECM-derived	 scaffolds	were	 non-
cytotoxic	 and	 had	 the	 capability	 to	 allow	 chondrogenic	 differentiation	 of	 human	 MSCs	
(chapter	seven).	However,	cell	migration	throughout	the	scaffold	was	non-existing	and	needs	
to	 be	 further	 improved	 to	 actually	 revitalize	 and	 thereby	 remodel	 tissue.	 Secondary,	 the	
complexity	of	cartilage	structures	in	the	head	and	neck	area	sets	high	standards	to	scaffold	
design.	 The	 shortage	of	 (allogeneic)	 donors	 and	 the	 inability	 to	 accurately	match	 cartilage	
shape	of	(allogeneic	or	xenogeneic)	donor	facial	cartilages,	impede	its	translation	to	clinical	
therapy.	 [295]	 Altogether,	we	 have	 introduced	 a	method	 to	 decellularized	 cartilage	 tissue	


























Alginate	 encapsulation	 enables	 homogeneous	 3D	 cell	 distribution	 and	 prevents	 cells	 from	
floating	out.	[387]	Meanwhile,	bacterial	nanocellulose	provides	excellent	cell	attachment	and	
migration,	although	cell	migration	is	limited	to	the	surface	of	the	scaffold	(i.e.	impermeability).	




of	 several	 tissues	 including	 cartilage.	 Besides,	 in	 order	 to	 secure	 a	 viable	 tissue,	 scaffolds	



















thesis)	making	 them	 attractive	 biocompatible	 scaffolds	 for	 the	 reconstruction	 of	 cartilage	
defect	in	the	head	and	neck	area.	
Another	 component	 of	 biocompatibility	 is	 biomaterial	 degradation,	 since	 the	 products	 of	





















Recent	 developments	 in	 3D	 bioprinting	 have	 brought	 immense	 excitement	 to	 the	 field	 of	
tissue	 engineering.	 In	 3D	 bioprinting,	 scaffold	 biomaterials	 and	 living	 cells	 are	 accurately	
deposited	in	a	layer-by-layer	fashion.	[397]	Thereby,	3D	bioprinting	has	the	ability	to	control	
spatial	placement	of	 living	cells	 relative	 to	 their	neighboring	cells	or	 scaffold	environment.	
Which	 in	 turn	 provides	 the	 ability	 to	 recreate	 the	 complexity	 of	 living	 tissues	 that	mimic	
natural	micro-architecture	of	the	targeted	tissue	itself.	The	primary	printing	technology	used	
for	 tissue	 engineering	 purposes	 is	 inkjet	 “drop-on-demand”	 bioprinting.	 [398]	 Essentially,	
inkjet	bioprinting	technology	is	based	on	digitally	controlled	ejection	of	drops	of	“bioink”	from	
a	print	head	onto	a	substrate.	These	bioinks	are	the	building	blocks	of	the	regenerated	tissue	
and	 contain	 livings	 cells	 and/or	 scaffold	 biomaterials.	 [399]	 Both	 alginate	 [400,	 401]	 and	



















The	 European	Medicines	 Agency	 (EMA)	 and	 the	 Food	 and	 Drug	 Administration	 (FDA)	 are	
responsible	 for	 the	 surveillance	 and	 evaluation	 of	 medicinal	 products	 and	 devices	 in	 the	
European	Union	and	United	States	respectively.	However,	the	lack	of	a	regulatory	framework	
for	 tissue-engineered	 products	 (TEPs)	 has	 significantly	 impeded	 the	 translation	 of	 tissue	
engineering	 therapies	 to	 clinical	 application.	 [407]	 The	 introduction	 of	 Advanced	 Therapy	
Medicinal	Products	(ATMPs)	in	the	European	Union	[408]	and	Human	Cells	and	Tissues	and	
Cellular-	and	Tissue-Based	Products	 (HCT/Ps)	 in	 the	United	States	 [409],	have	substantially	
contributed	to	global	biotechnology	market	growth	[410]	and	provide	a	 legitimate	tool	 for	
overseeing	 TEPs.	 At	 present,	 only	 few	 cell-based	 therapies	 are	 awarded	 marketing	
authorization	by	the	EMA	or	FDA.	[410,	411]	Of	these	TEPs,	CarticelTM,	ChondroCelect®	and	
MACI®	 are	 the	 only	 licensed	 therapies	 for	 the	 reconstruction	 of	 cartilage	 defects.	 These	











requirements,	 product	 traceability	 and	 reproducibility.	 Considering	 this,	 the	 translation	 of	





Tissue	 engineering	 strategies	 could	 technically	 simplify	 and	 thereby	 improve	 the	 surgical	
treatment	of	 cartilage	defect	 in	 the	head	and	neck	area.	Although	our	 research	 could	not	
directly	translate	towards	a	clinical	cell-based	therapy,	 it	has	 identified	potential	 for	future	
translational	 research.	 First,	 the	 combination	 of	 chondrocytes	 and	 MSCs	 has	 held	 great	
promise	for	cell-based	cartilage	repair	in	the	head	and	neck	area.	For	implementation	of	such	
therapy,	an	optimal	cell	density	and	ratio	of	MSCs	to	chondrocytes	is	imperative.	Puelacher	et	










from	 “cell-based”	 towards	 “cell-free”	 regenerative	 therapies.	 [414]	 Acellular	 biomaterials	
mimic	native	ECM	and	thereby	attract	native	progenitor	cells	to	migrate	into	the	biomaterial	
and	 trigger	 chondrogenic	 differentiation.	 To	 date,	 acellular	 biomaterials	 have	 shown	




cancer)	 or	 genetically	 diseased	 (i.e.	 congenital	 remnants).	 Therefore,	 for	 future	 cell-based	
cartilage	repair	in	the	head	and	neck	area	a	cellular	3D	scaffold	that	-	at	least	partially	-	mimics	
structural	and	functional	characteristics	of	native	tissue	microenvironment	is	imperative.		
	 In	 conclusion,	 this	 thesis	 has	 focussed	 on	 the	 generation	 of	 a	 tissue-engineered	
cartilaginous	framework	for	the	reconstruction	of	cartilage	defects	in	the	head	and	neck	area	
  
and	has	 identified	potential	 for	 future	 translational	 research.	 For	 cell	 source	 selection,	we	



























head	 and	 neck	 area	 and	 has	 the	 potential	 to	 overcome	 limitations	 of	 current	 treatments,	
reestablishing	unique	biological	and	functional	properties	of	the	tissue.	This	thesis	focuses	on	
the	requirements	that	are	necessary	for	future	cell-based	cartilage	repair	in	the	head	and	neck	
area.	 Specifically,	 the	 suitability	 of	 cells	 or	 combination	 of	 cells	 on	 natural	 scaffolds	were	
evaluated.		
	 Cartilage	is	a	highly	complex	avascular	tissue	comprising	chondrocytes	surrounded	by	









MPa.	 Ear	 cartilage	 had	 significantly	 lower	 stiffness	 compared	 to	 nasal	 cartilage,	 although	






the	 ability	 to	 obtain	 sufficient	 numbers	 of	 chondrocytes,	 necessitating	 the	 use	 of	 culture-
expansion.	 During	 culture	 expansion,	 chondrocytes	 change	 phenotypically	 to	 a	 fibroblast	
morphology	 and	 lose	 their	 chondrogenic	 potential;	 they	 dedifferentiate.	 Second,	
mesenchymal-stem-cell-based	 cartilage	 repair	 is	 hampered	 by	 the	 phenomenon	 of	
chondrocyte	 hypertrophy.	 During	 chondrogenic	 differentiation,	 they	 undergo	 terminal	
differentiation	through	the	process	of	endochondral	ossification	and	produce	cartilage	that	is	
unstable	 and	 predisposed	 to	 mineralization	 and	 ossification	 in	 vivo.	 In	 chapter	 four,	 the	
cartilage-forming	 capacity	 of	 cells	 from	 several	 anatomical	 locations	 were	 studied.	
Independent	on	their	origin	(i.e.	articular	joint,	ear,	and	nose),	culture-expanded	chondrocytes	





diminishes	 many	 disadvantages	 of	 the	 individual	 cell	 types.	 Co-cultures	 of	 primary	
chondrocytes	 (i.e.	articular,	ear,	and	nasal	chondrocytes)	and	mesenchymal	stem	cells	 (i.e.	





or	 nasal	 chondrocytes.	 Meanwhile,	 large	 differences	 between	 adipose-tissue-derived	 and	





herein	 appeared	 essential	 rather	 than	 mesenchymal	 stem	 cells	 actively	 undergoing	
chondrogenic	differentiation.	We	showed	that	stem	cell	trophic	function	is	a	general	feature	
that	 applies	 to	 both	 adipose-tissue-derived	 and	 bone-marrow-derived	mesenchymal	 stem	
cells.	Co-culture	supports	the	application	of	a	one-stage	cell-based	cartilage	repair	procedure	
for	cartilage	defects	in	the	head	and	neck	area.	Ear	and	nasal	chondrocytes	in	combination	







extracellular	 matrix	 is	 best	 retained	 through	 the	 process	 of	 decellularization.	 The	
decellularization	protocol	described	 in	chapter	seven	preserved	native	collagen	and	elastin	
contents	 of	 full-thickness	 ear	 cartilage	 tissue,	 as	 well	 as	 cartilage	 major	 architecture	 and	
shape.	Moreover,	decellularized	 scaffolds	were	non-cytotoxic	and	 supported	chondrogenic	




defect	 in	 the	 head	 and	 neck	 area.	 Therefore,	 natural	 scaffolds,	 in	 particular	 alginate	 and	
bacterial	 nanocellulose	 have	 been	 further	 characterized	 for	 their	 use	 in	 cartilage	 tissue	
engineering.	 Both	 alginate	 and	 bacterial	 nanocellulose	 scaffolds	 support	 cartilage	 tissue	
regeneration	and	homeostasis.	Besides,	bacterial	nanocellulose	has	biomechanical	properties	























Kraakbeendefecten	 in	 het	 hoofd-/halsgebied	 zijn	 een	 uitdagend	 probleem	 voor	 de	
reconstructief	 chirurg.	 Kraakbeen	 tissue	 engineering	 lijkt	 een	 veelbelovende	 alternatieve	




de	 vorm	 en	 functie	 van	 onder	 andere	 oren	 en	 neus.	 Het	 bestaat	 voor	 een	 fractie	 uit	
chondrocyten	 omgeven	 door	 een	 grote	 hoeveelheid	 extracellulaire	matrix.	 De	 opbouw	en	
structuur	van	deze	matrix	bepaalt	de	eigenschappen	van	het	kraakbeen,	waarbij	grofweg	drie	
typen	onderscheiden	kunnen	worden:	hyalien,	 elastisch	en	 fibrotisch	 kraakbeen.	Wanneer	
kraakbeen	 in	 het	 hoofd-/halsgebied	 beschadigd	 is	 geraakt	 of	 congenitaal	 onvoldoende	
gevormd,	herstelt	het	zich	niet	of	nauwelijks.	Tissue	engineering,	oftewel	de	regeneratie	van	
weefsel	 uit	 levende	 cellen,	 is	 mogelijk	 een	 veelbelovende	 alternatieve	 therapie	 voor	 de	
behandeling	van	deze	defecten.	In	hoofdstuk	één	worden	de	eigenschappen	en	moleculaire	
samenstelling	van	de	verschillende	kraakbeentypen	beschreven.	Daarnaast	wordt	het	concept	
van	 tissue	 engineering	 geïntroduceerd	 en	 welke	 rol	 deze	 zou	 kunnen	 hebben	 bij	 de	
reconstructie	van	kraakbeendefecten	in	het	hoofd-/halsgebied.	
	 Voor	 kraakbeen	 tissue	 engineering	 is	 het	 allereerst	 van	 belang	 de	 intrinsieke	
kenmerken	van	het	oorspronkelijke	weefsel	te	kennen,	zodat	een	benchmark	verkregen	kan	
worden	waarmee	getissue-engineerd	kraakbeen	vergeleken	kan	worden.	In	hoofdstuk	twee	
en	 drie	worden	 de	 biomechanische	 en	 biochemische	 eigenschappen	 van	 humaan	 oor-	 en	
neuskraakbeen	 (septum	 en	 ala	 nasi)	 uitvoerig	 geanalyseerd.	 In	 het	 algemeen	 kon	 gesteld	
worden	dat	de	biomechanische	eigenschappen	 (uitgedrukt	 in	 indentatie	 Eeq)	 van	humaan	
volwassen	 kraakbeen	 van	 het	 aangezicht	 varieerden	 van	 1-15	 MPa.	 Oorkraakbeen	 had	
aanzienlijk	lagere	biomechanische	eigenschappen	in	vergelijking	met	neuskraakbeen,	hoewel	
er	 regionale	 variaties	 werden	 waargenomen	 binnen	 de	 verschillende	 kraakbeentypen.	 De	
biomechanische	 eigenschappen	 van	 oorkraakbeen	 konden	 voornamelijk	 worden	
toegeschreven	 aan	 de	 aanwezigheid	 van	 elastine	 in	 de	 extracellulaire	 matrix	 van	
oorkraakbeen.	
Het	 selecteren	van	cellen	of	een	combinatie	 van	 cellen	 is	 van	 cruciaal	belang	 in	de	
regeneratieve	 geneeskunde.	 Momenteel	 is	 kraakbeen	 tissue	 engineering	 voornamelijk	
gebaseerd	op	twee	verschillende	soorten	cellen,	namelijk:	chondrocyten	en	mesenchymale	
stamcellen.	Wanneer	deze	cellen	echter	onafhankelijk	van	elkaar	worden	gebruikt,	brengt	dat	





kraakbeeneigenschappen:	 zij	 dedifferentiëren.	 Ten	 tweede,	 kraakbeen	 tissue	 engineering	
gebaseerd	op	alléén	mesenchymale	stamcellen	wordt	belemmerd	door	het	feit	dat	stamcellen	
tijdens	het	differentiatieproces	van	stamcel	naar	chondrocyt	niet	in	staat	zijn	kraakbenig	te	
blijven	 en	 uiteindelijk	 terminaal	 differentiëren	 via	 het	 proces	 van	 enchondrale	 ossificatie.	
Terminaal	gedifferentieerd	(of	hypertrofisch)	kraakbeen	is	instabiel	en	heeft	een	grote	kans	
  
te	 mineraliseren	 en	 ossificeren	 in	 vivo.	 In	 hoofdstuk	 vier	 wordt	 de	 kraakbeenvormende	
capaciteit	 van	 verschillende	 cellen	 van	 verschillende	 anatomische	 locaties	 vergeleken.	
Geëxpandeerde	 chondrocyten	 dedifferentieerden	 onafhankelijk	 van	 hun	 origine	 (gewricht,	
oor,	neus).	Na	chondrogene	stimulatie	bleken	chondrocyten	van	oor-	en	neuskraakbeen	het	
meest	 potent	 voor	 kraakbeen	 tissue	 engineering	 in	 vivo.	 Tevens	 waren	 locatie-	 en	
kraakbeentype	 specifieke	 chondrocyten	 in	 staat	 kraakbeen	 te	 produceren	 met	 specifieke	
kraakbeeneigenschappen	en	moleculaire	 samenstelling,	 gerelateerd	aan	de	eigenschappen	
van	het	originele	donorkraakbeen.	Dit	betekent	dat	chondrocyten	van	oor-	en	neuskraakbeen	
het	 meest	 geschikt	 lijken	 voor	 de	 reconstructie	 van	 oor-	 en	 neuskraakbeendefecten	
respectievelijk.	
Recente	 inzichten	 tonen	 dat	 de	 combinatie	 van	 chondrocyten	 en	 mesenchymale	
stamcellen	(“co-kweken”)	een	positief	effect	heeft	op	de	kraakbeenvorming	en	daardoor	een	
veelbelovend	 concept	 lijkt	 voor	 de	 behandeling	 van	 kraakbeendefecten	 in	 het	 hoofd-
/halsgebied.	 “Co-kweken”	 heeft	 een	 aantal	 voordelen	 ten	 opzicht	 van	 het	 onafhankelijk	
gebruik	van	cellen	zoals	eerder	beschreven.	Door	het	combineren	van	cellen,	kan	een	groot	
aantal	 chondrocyten	 vervangen	 worden	 door	 mesenchymale	 stamcellen.	 Hierdoor	 kan	
gebruik	worden	gemaakt	van	primaire	cellen;	cellen	die	direct	ingezet	kunnen	worden	voor	
reconstructiedoeleinden	zonder	een	daar	voorafgaande	 in	vitro	expansie	fase.	In	hoofdstuk	
vijf	 en	 zes	 wordt	 het	 “co-kweken”	 van	 primaire	 chondrocyten	 (gewricht,	 oor,	 neus)	 in	
combinatie	 met	 mesenchymale	 stamcellen	 (vet,	 beenmerg)	 verder	 bestudeerd.	
Kraakbeenproductie	 en	 stabiliteit	werden	 niet	 negatief	 beïnvloed	 door	 het	 vervangen	 van	
tachtig	procent	van	de	chondrocyten	door	mesenchymale	stamcellen.	Kraakbeen	regeneratie	






verschillende	 typen	 chondrocyten	 (gewricht,	 oor,	 neus).	 Ook	 in	 “co-kweek”	 waren	 deze	
locatie-	 en	 kraakbeentype	 specifieke	 chondrocyten	 in	 staat	 kraakbeen	 te	 produceren	met	
specifieke	eigenschappen	gerelateerd	aan	het	originele	donorkraakbeen.	De	combinatie	van	
primaire	chondrocyten	en	mesenchymale	stamcellen,	voorkomt	een	periode	van	expansie,	en	
ondersteunt	 de	 mogelijkheid	 om	 in	 de	 toekomst	 een	 één-stap-techniek	 te	 kunnen	
verwezenlijken	 voor	 de	 behandeling	 van	 kraakbeendefect	 in	 het	 hoofd-/halsgebied.	
Chondrocyten	 van	 oor-	 en	 neuskraakbeen	 in	 combinatie	 met	 mesenchymale	 stamcellen	










van	 bovien	 en	 humaan	 oorkraakbeen	 beschreven.	 Na	 decellularisatie,	 werd	 een	 matrix	
gerealiseerd	waarin	geen	cellen	of	celresten	meer	konden	worden	aangetoond.	Daarnaast,	
kon	 de	 hoeveelheid	 collageen	 en	 elastine	 tijdens	 het	 decellulalarisatieproces	 behouden	
blijven,	evenals	de	vorm	en	architectuur	van	het	 kraakbeen.	Gedecellulariseerd	kraakbeen	





kraakbeendefecten	 in	 het	 hoofd-/halsgebied,	 lijkt	 heden	 belemmerd	 door	 een	 tekort	 aan	
donoren	 en	 het	 onvermogen	 om	 de	 kraakbeenvorm	 van	 de	 donor	 nauwkeurig	 te	 laten	
overeenkomen	met	de	specifieke	eisen	van	het	te	regenereren	kraakbeen	in	het	aangezicht.	
Naast	gedecellulariseerde	scaffolds	-	scaffolds	die	zijn	geëxtraheerd	vanuit	de	oorspronkelijk	
extracellulaire	 matrix	 -	 zijn	 er	 ook	 scaffolds	 in	 ontwikkeling	 die	 de	 driedimensionale	
architectuur	 van	 oorspronkelijke	 matrix	 zoveel	 mogelijk	 proberen	 na	 te	 bootsen.	 Deze	
scaffolds	kunnen	grofweg	onderverdeeld	worden	in	natuurlijke	en	synthetische	scaffolds.	In	
dit	 proefschrift	 wordt	 specifiek	 gebruik	 gemaakt	 van	 twee	 natuurlijk	 scaffolds,	 te	 weten	
alginaat	en	bacterieel	nanocellulose.	Beide	scaffolds	ondersteunen	kraakbeenregeneratie	en	
–hemostase.	Daarnaast	zijn	de	biomechanische	eigenschappen	van	bacterieel	nanocellulose	






te	ondersteunen	 in	 vitro	en	 in	 vivo.	De	combinatie	van	beide	materialen	 lijkt	dan	ook	een	
potentiële	therapie	voor	de	reconstructie	van	kraakbeendefecten	in	het	hoofd-/halsgebied.	
De	 resultaten	 van	 dit	 proefschrift	 zijn	 een	 belangrijke	 stap	 voor	 de	 toekomstige	
behandeling	 van	 kraakbeendefecten	 in	het	hoofd-/halsgebied.	Door	 gebruik	 te	maken	 van	
tissue-engineering	technieken	kunnen	huidige	chirurgisch	technieken	worden	vereenvoudigd	
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